1
|
Amaducci S, Colonna N, Cosentino L, Cristallo S, Finocchiaro P, Krtička M, Massimi C, Mastromarco M, Mazzone A, Maugeri EA, Mengoni A, Roederer IU, Straniero O, Valenta S, Vescovi D, Aberle O, Alcayne V, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Billowes J, Bosnar D, Brown A, Busso M, Caamaño M, Caballero-Ontanaya L, Calviño F, Calviani M, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Cortés G, Cortés-Giraldo MA, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domínguez B, Ferrari A, Furman V, Göbel K, Garg R, Gawlik-Ramięga A, Gilardoni S, Gonçalves IF, González-Romero E, Guerrero C, Gunsing F, Harada H, Heinitz S, Heyse J, Jenkins DG, Junghans A, Käppeler F, Kadi Y, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Kurtulgil D, Ladarescu I, Lederer-Woods C, Leeb H, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Mastinu P, Mendoza E, Michalopoulou V, Milazzo PM, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Nolte R, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Ramos-Doval D, Rauscher T, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin NV, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia A, Tassan-Got L, Thomas T, Torres-Sánchez P, Tsinganis A, Ulrich J, Urlass S, Vannini G, Variale V, Vaz P, Ventura A, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright T, Žugec P. Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe. Phys Rev Lett 2024; 132:122701. [PMID: 38579210 DOI: 10.1103/physrevlett.132.122701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 11/09/2023] [Accepted: 01/31/2024] [Indexed: 04/07/2024]
Abstract
^{140}Ce(n,γ) is a key reaction for slow neutron-capture (s-process) nucleosynthesis due to being a bottleneck in the reaction flow. For this reason, it was measured with high accuracy (uncertainty ≈5%) at the n_TOF facility, with an unprecedented combination of a high purity sample and low neutron-sensitivity detectors. The measured Maxwellian averaged cross section is up to 40% higher than previously accepted values. Stellar model calculations indicate a reduction around 20% of the s-process contribution to the Galactic cerium abundance and smaller sizeable differences for most of the heavier elements. No variations are found in the nucleosynthesis from massive stars.
Collapse
Affiliation(s)
- S Amaducci
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | - N Colonna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - L Cosentino
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | - S Cristallo
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | | | - M Krtička
- Charles University, Prague, Czech Republic
| | - C Massimi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - M Mastromarco
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Mazzone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- Consiglio Nazionale delle Ricerche, Bari, Italy
| | - E A Maugeri
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - A Mengoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), Italy
| | - I U Roederer
- Department of Physics, North Carolina State University, Raleigh, Norh Carolina 27695, USA
- Department of Astronomy, University of Michigan, Ann Arbor, Michigan 48109, USA
- Joint Institute for Nuclear Astrophysics-Center for the Evolution of the Elements (JINA-CEE), USA
| | - O Straniero
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- INFN Sezione Napoli, Napoli, Italy
| | - S Valenta
- Charles University, Prague, Czech Republic
| | - D Vescovi
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | - O Aberle
- European Organization for Nuclear Research (CERN), Switzerland
| | - V Alcayne
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - L Audouin
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
| | - V Babiano-Suarez
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - M Bacak
- European Organization for Nuclear Research (CERN), Switzerland
- TU Wien, Atominstitut, Stadionallee 2, 1020 Wien, Austria
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - M Barbagallo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- European Organization for Nuclear Research (CERN), Switzerland
| | - S Bennett
- University of Manchester, United Kingdom
| | - E Berthoumieux
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - J Billowes
- University of Manchester, United Kingdom
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - A Brown
- University of York, United Kingdom
| | - M Busso
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
- Dipartimento di Fisica e Geologia, Università di Perugia, Italy
| | - M Caamaño
- IGFAE-Universidade de Santiago de Compostela, Spain
| | | | - F Calviño
- Universitat Politècnica de Catalunya, Spain
| | - M Calviani
- European Organization for Nuclear Research (CERN), Switzerland
| | - D Cano-Ott
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - F Cerutti
- European Organization for Nuclear Research (CERN), Switzerland
| | - E Chiaveri
- European Organization for Nuclear Research (CERN), Switzerland
- University of Manchester, United Kingdom
| | - G Cortés
- Universitat Politècnica de Catalunya, Spain
| | | | - L A Damone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- Dipartimento Interateneo di Fisica, Università degli Studi di Bari, Italy
| | - P J Davies
- University of Manchester, United Kingdom
| | - M Diakaki
- European Organization for Nuclear Research (CERN), Switzerland
- National Technical University of Athens, Greece
| | - M Dietz
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - R Dressler
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - Q Ducasse
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | - E Dupont
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - I Durán
- IGFAE-Universidade de Santiago de Compostela, Spain
| | - Z Eleme
- University of Ioannina, Greece
| | | | - A Ferrari
- European Organization for Nuclear Research (CERN), Switzerland
| | - V Furman
- Affiliated with an institute or an international laboratory covered by a cooperation agreement with CERN
| | - K Göbel
- Goethe University Frankfurt, Germany
| | - R Garg
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | | | - S Gilardoni
- European Organization for Nuclear Research (CERN), Switzerland
| | | | - E González-Romero
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - F Gunsing
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - H Harada
- Japan Atomic Energy Agency (JAEA), Tokai-Mura, Japan
| | - S Heinitz
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - J Heyse
- European Commission, Joint Research Centre (JRC), Geel, Belgium
| | | | - A Junghans
- Helmholtz-Zentrum Dresden-Rossendorf, Germany
| | - F Käppeler
- Karlsruhe Institute of Technology, Campus North, IKP, 76021 Karlsruhe, Germany
| | - Y Kadi
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Kimura
- Japan Atomic Energy Agency (JAEA), Tokai-Mura, Japan
| | - I Knapová
- Charles University, Prague, Czech Republic
| | - M Kokkoris
- National Technical University of Athens, Greece
| | - Y Kopatch
- Affiliated with an institute or an international laboratory covered by a cooperation agreement with CERN
| | | | - I Ladarescu
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - C Lederer-Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - H Leeb
- TU Wien, Atominstitut, Stadionallee 2, 1020 Wien, Austria
| | | | - S J Lonsdale
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - D Macina
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Manna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - T Martínez
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | - A Masi
- European Organization for Nuclear Research (CERN), Switzerland
| | - P Mastinu
- INFN Laboratori Nazionali di Legnaro, Italy
| | - E Mendoza
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | - V Michalopoulou
- European Organization for Nuclear Research (CERN), Switzerland
- National Technical University of Athens, Greece
| | - P M Milazzo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Italy
| | - F Mingrone
- European Organization for Nuclear Research (CERN), Switzerland
| | - J Moreno-Soto
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Musumarra
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania, Italy
- Department of Physics and Astronomy, University of Catania, Italy
| | - A Negret
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | - R Nolte
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | | | - A Oprea
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | | | - A Pavlik
- University of Vienna, Faculty of Physics, Vienna, Austria
| | | | - C Petrone
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | - L Piersanti
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | - E Pirovano
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | | | | | | | - D Ramos-Doval
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
| | - T Rauscher
- Department of Physics, University of Basel, Switzerland
- Centre for Astrophysics Research, University of Hertfordshire, United Kingdom
| | | | - D Rochman
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - C Rubbia
- European Organization for Nuclear Research (CERN), Switzerland
| | - M Sabaté-Gilarte
- European Organization for Nuclear Research (CERN), Switzerland
- Universidad de Sevilla, Spain
| | - A Saxena
- Bhabha Atomic Research Centre (BARC), India
| | - P Schillebeeckx
- European Commission, Joint Research Centre (JRC), Geel, Belgium
| | - D Schumann
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - A Sekhar
- University of Manchester, United Kingdom
| | - A G Smith
- University of Manchester, United Kingdom
| | - N V Sosnin
- University of Manchester, United Kingdom
| | - P Sprung
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | | | - G Tagliente
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - J L Tain
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | | | - L Tassan-Got
- European Organization for Nuclear Research (CERN), Switzerland
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
- National Technical University of Athens, Greece
| | - Th Thomas
- Goethe University Frankfurt, Germany
| | | | - A Tsinganis
- European Organization for Nuclear Research (CERN), Switzerland
| | - J Ulrich
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - S Urlass
- European Organization for Nuclear Research (CERN), Switzerland
- Helmholtz-Zentrum Dresden-Rossendorf, Germany
| | - G Vannini
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - V Variale
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - P Vaz
- Instituto Superior Técnico, Lisbon, Portugal
| | - A Ventura
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - V Vlachoudis
- European Organization for Nuclear Research (CERN), Switzerland
| | - R Vlastou
- National Technical University of Athens, Greece
| | - A Wallner
- Australian National University, Canberra, Australia
| | - P J Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - T Wright
- University of Manchester, United Kingdom
| | - P Žugec
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| |
Collapse
|
2
|
Terrones-Campos C, Ledergerber B, Forbes N, Smith AG, Petersen J, Helleberg M, Lundgren J, Specht L, Vogelius IR. Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality. Clin Oncol (R Coll Radiol) 2023; 35:e434-e444. [PMID: 37149425 DOI: 10.1016/j.clon.2023.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 02/08/2023] [Accepted: 04/11/2023] [Indexed: 05/08/2023]
Abstract
AIMS Large blood volumes are irradiated when the heart is exposed to radiation. The mean heart dose (MHD) may be a good surrogate for circulating lymphocytes exposure. We investigated the association between MHD and radiation-induced lymphopenia and explored the impact of the end-of-radiation-therapy (EoRT) lymphocyte count on clinical outcomes. MATERIALS AND METHODS In total, 915 patients were analysed: 303 patients with breast cancer and 612 with intrathoracic tumours: oesophageal cancer (291), non-small cell lung cancer (265) and small cell lung cancer (56). Heart contours were generated using an interactive deep learning delineation process and an individual dose volume histogram for each heart was obtained. A dose volume histogram for the body was extracted from the clinical systems. We compared different models analysing the effect of heart dosimetry on the EoRT lymphocyte count using multivariable linear regression and assessed goodness of fit. We published interactive nomograms for the best models. The association of the degree of EoRT lymphopenia with clinical outcomes (overall survival, cancer treatment failure and infection) was investigated. RESULTS An increasing low dose bath to the body and MHD were associated with a low EoRT lymphocyte count. The best models for intrathoracic tumours included dosimetric parameters, age, gender, number of fractions, concomitant chemotherapy and pre-treatment lymphocyte count. Models for patients with breast cancer showed no improvement when adding dosimetric variables to the clinical predictors. EoRT lymphopenia grade ≥3 was associated with decreased survival and increased risk of infections among patients with intrathoracic tumours. CONCLUSION Among patients with intrathoracic tumours, radiation exposure to the heart contributes to lymphopenia and low levels of peripheral lymphocytes after radiotherapy are associated with worse clinical outcomes.
Collapse
Affiliation(s)
- C Terrones-Campos
- Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
| | - B Ledergerber
- Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - N Forbes
- Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - A G Smith
- Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Computer Science, University of Copenhagen, Copenhagen, Denmark
| | - J Petersen
- Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Computer Science, University of Copenhagen, Copenhagen, Denmark
| | - M Helleberg
- Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - J Lundgren
- Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - L Specht
- Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - I R Vogelius
- Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
3
|
Bennett SA, Garrett K, Sharp DK, Freeman SJ, Smith AG, Wright TJ, Kay BP, Tang TL, Tolstukhin IA, Ayyad Y, Chen J, Davies PJ, Dolan A, Gaffney LP, Heinz A, Hoffman CR, Müller-Gatermann C, Page RD, Wilson GL. Direct Determination of Fission-Barrier Heights Using Light-Ion Transfer in Inverse Kinematics. Phys Rev Lett 2023; 130:202501. [PMID: 37267578 DOI: 10.1103/physrevlett.130.202501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2022] [Revised: 02/28/2023] [Accepted: 03/27/2023] [Indexed: 06/04/2023]
Abstract
We demonstrate a new technique for obtaining fission data for nuclei away from β stability. These types of data are pertinent to the astrophysical r process, crucial to a complete understanding of the origin of the heavy elements, and for developing a predictive model of fission. These data are also important considerations for terrestrial applications related to power generation and safeguarding. Experimentally, such data are scarce due to the difficulties in producing the actinide targets of interest. The solenoidal-spectrometer technique, commonly used to study nucleon-transfer reactions in inverse kinematics, has been applied to the case of transfer-induced fission as a means to deduce the fission-barrier height, among other variables. The fission-barrier height of ^{239}U has been determined via the ^{238}U(d,pf) reaction in inverse kinematics, the results of which are consistent with existing neutron-induced fission data indicating the validity of the technique.
Collapse
Affiliation(s)
- S A Bennett
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - K Garrett
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - D K Sharp
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - S J Freeman
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
- CERN, CH-1211 Geneva 23, Switzerland
| | - A G Smith
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - T J Wright
- Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - B P Kay
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - T L Tang
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - I A Tolstukhin
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - Y Ayyad
- IGFAE, Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain
| | - J Chen
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - P J Davies
- School of Physics, Engineering and Technology, University of York, Heslington, York YO10 5DD, United Kingdom
| | - A Dolan
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Heinz
- Chalmers University of Technology, SE-41296 Göteborg, Sweden
| | - C R Hoffman
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - C Müller-Gatermann
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - G L Wilson
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
- Louisiana State University, Baton Rouge, Louisiana 70803, USA
| |
Collapse
|
4
|
Mvalo T, Smith AG, Eckerle M, Hosseinipour MC, Kondowe D, Vaidya D, Liu Y, Corbett K, Nansongole D, Mtimaukanena TA, Lufesi N, McCollum ED. Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis. PLoS One 2022; 17:e0278938. [PMID: 36516197 PMCID: PMC9750006 DOI: 10.1371/journal.pone.0278938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Accepted: 11/21/2022] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia. METHODS Participants were 1-59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3-6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics. RESULTS From June 2015-March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure. CONCLUSION Severe malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes.
Collapse
Affiliation(s)
- Tisungane Mvalo
- University of North Carolina Project Malawi, Lilongwe, Malawi
- Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America
- * E-mail:
| | - Andrew G. Smith
- Division of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America
| | - Michelle Eckerle
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America
- Division of Pediatric Emergency Medicine, Cincinnati Children’s Hospital, Cincinnati, OH, United States of America
| | - Mina C. Hosseinipour
- University of North Carolina Project Malawi, Lilongwe, Malawi
- Division of Infectious Disease, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America
| | - Davie Kondowe
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | - Dhananjay Vaidya
- Department of Medicine, Epidemiology and the BEAD Core, Johns Hopkins University, Baltimore, MD, United States of America
| | - Yisi Liu
- Department of Pediatrics and the BEAD Core, Johns Hopkins University, Baltimore, MD, United States of America
| | - Kelly Corbett
- Department of Pediatrics, Section of Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States of America
| | - Dan Nansongole
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | | | | | - Eric D. McCollum
- Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Global Program for Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States of America
- Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America
| |
Collapse
|
5
|
Bagley MB, Smith AG, Morton DA, Chow CJ. "I really liked the chance to talk about it": Students' Reflections on the Process of Completing Paper Puzzles, a Novel Active Learning Activity. Med Sci Educ 2022; 32:1503-1511. [PMID: 36415501 PMCID: PMC9672609 DOI: 10.1007/s40670-022-01682-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Accepted: 11/07/2022] [Indexed: 06/16/2023]
Abstract
INTRODUCTION Research shows active learning is an effective teaching method. However, few qualitative studies explore medical student perceptions of the active learning process. The present study explored what students thought about while completing paper puzzles, an active learning tool used at the University of Utah School of Medicine, to understand what and how medical students think while engaged in active learning. MATERIALS AND METHODS To investigate second-year medical students' attitudes toward these active learning exercises, three Zoom-based focused groups were held and recorded throughout the course. Recordings were transcribed and coded using thematic analysis. RESULTS Students reported that peer interactions were of high value, and that while some interactions and thought processes were action-oriented, others were more metacognitive. Other benefits of the activity included promotion of learning, provision of structure, and designation of high-yield concepts. Challenges included feelings of confusion, problems with timing or difficulty of the tasks, and low utility without adequate preparation. DISCUSSION These findings reflect student-acknowledged pros and cons of active learning described in education literature and add further insight into the thoughts and conversations students have during active learning activities. These include practicing metacognitive skills, triaging information, and learning from peers. CONCLUSIONS These data further elucidate student perceptions of active learning activities in medical education. Though focused on a specific activity, the data can help medical educators understand what students appreciate about active learning and what they think about while engaged in such activities. SUPPLEMENTARY INFORMATION The online version contains supplementary material available at 10.1007/s40670-022-01682-y.
Collapse
Affiliation(s)
| | - Andrew G. Smith
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT USA
| | - David A. Morton
- Department of Neurobiology, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Candace J. Chow
- Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT USA
| |
Collapse
|
6
|
Pippitt KA, Moore KB, Lindsley JE, Cariello PF, Smith AG, Formosa T, Moser K, Morton DA, Colbert-Getz JM, Chow CJ. Assessment for Learning with Ungraded and Graded Assessments. Med Sci Educ 2022; 32:1045-1054. [PMID: 36276764 PMCID: PMC9584017 DOI: 10.1007/s40670-022-01612-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 08/25/2022] [Indexed: 06/16/2023]
Abstract
Introduction Assessment for learning has many benefits, but learners will still encounter high-stakes decisions about their performance throughout training. It is unknown if assessment for learning can be promoted with a combination model where scores from some assessments are factored into course grades and scores from other assessments are not used for course grading. Methods At the University of Utah School of Medicine, year 1-2 medical students (MS) completed multiple-choice question quiz assessments and final examinations in six systems-based science courses. Quiz and final examination performance counted toward course grades for MS2017-MS2018. Starting with the MS2020 cohort, quizzes no longer counted toward course grades. Quiz, final examination, and Step 1 scores were compared between ungraded quiz and graded quiz cohorts with independent samples t-tests. Student and faculty feedback was collected. Results Quiz performance was not different for the ungraded and graded cohorts (p = 0.173). Ungraded cohorts scored 4% higher on final examinations than graded cohorts (p ≤ 0.001, d = 0.88). Ungraded cohorts scored above the national average and 11 points higher on Step 1 compared to graded cohorts, who had scored below the national average (p ≤ 0.001, d = 0.64). During the study period, Step 1 scores increased by 2 points nationally. Student feedback was positive, and faculty felt it improved their relationship with students. Discussion The change to ungraded quizzes did not negatively affect final examination or Step 1 performance, suggesting a combination of ungraded and graded assessments can effectively promote assessment for learning.
Collapse
Affiliation(s)
- Karly A. Pippitt
- Department of Family and Preventive Medicine, University of Utah School of Medicine, 317 Chipeta Way, Suite A, Salt Lake City, UT 84108 USA
- Community Faculty, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Kathryn B. Moore
- Department of Neurobiology, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Janet E. Lindsley
- Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT USA
- Curriculum University of Utah School of Medicine, Salt Lake City, UT USA
| | - Paloma F. Cariello
- Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT USA
- Health Equity, Diversity, and Inclusion, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Andrew G. Smith
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Tim Formosa
- Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Karen Moser
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT USA
| | - David A. Morton
- Department of Neurobiology, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Jorie M. Colbert-Getz
- Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT USA
- Education Quality Improvement, University of Utah School of Medicine, Salt Lake City, UT USA
| | - Candace J. Chow
- Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT USA
- Education Research, University of Utah School of Medicine, Salt Lake City, UT USA
| |
Collapse
|
7
|
Abstract
BACKGROUND High-frequency percussive ventilation (HFPV) is an alternative mode of mechanical ventilation that has been shown to improve gas exchange in subjects with severe respiratory failure. We hypothesized that HFPV use would improve ventilation and oxygenation in intubated children with acute bronchiolitis. METHODS In this single-center prospective cohort study we included mechanically ventilated children in the pediatric ICU with bronchiolitis 1-24 months old who were transitioned to HFPV from conventional invasive mechanical ventilation from November 2018-April 2020. Patients with congenital heart disease, on extracorporeal membrane oxygenation (ECMO), and with HFPV duration < 12 h were excluded. Subject gas exchange metrics and ventilator parameters were compared before and after HFPV initiation. RESULTS Forty-one of 192 (21%) patients intubated with bronchiolitis underwent HFPV, and 35 met inclusion criteria. Median age of cohort was 4 months, and 60% were previously healthy. All subjects with available oxygenation saturation index (OSI) measurements pre-HFPV met pediatric ARDS criteria (31/35, 89%). Mean CO2 decreased from 65.4 in the 24 h pre-HFPV to 51 (P < .001) in the 24 h post initiation. SpO2 /FIO2 was significantly improved at 24 h post-HFPV (153.3 to 209.7, P = .001), whereas the decrease in mean OSI at 24 h did not meet statistical significance (11.9 to 10.2, P = .15). The mean peak inspiratory pressure (PIP) decreased post-HFPV from 29.7 to 25.0 at 24 h (P < .001). No subjects developed an air leak or hemodynamic instability secondary to HFPV. Two subjects required ECMO, and of these, one subject died. CONCLUSIONS HFPV was associated with significant improvement in ventilation and decreased exposure to high PIPs for mechanically ventilated children with bronchiolitis in our cohort and had a potential association with improved oxygenation. Our study shows that HFPV may be an effective alternative mode of ventilation in patients with bronchiolitis who have poor gas exchange on conventional invasive mechanical ventilation.
Collapse
Affiliation(s)
- Benjamin R White
- Department of Pediatrics, Division of Pediatric Critical Care, Penn State Health Children's Hospital, Hershey, Pennsylvania.
| | - Noelle Cadotte
- Department of Pediatrics, Division of Pediatric Critical Care, University of Utah, Salt Lake City, Utah
| | - Eric B McClellan
- Department of Pediatrics, Division of Cardiology, University of Michigan, Ann Arbor, Michigan
| | - Angela P Presson
- Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah
| | - Erin Bennett
- Department of Pediatrics, Division of Critical Care, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Andrew G Smith
- Department of Pediatrics, Division of Pediatric Critical Care, University of Utah, Salt Lake City, Utah
| | - Salim Aljabari
- Department of Pediatrics, Division of Pediatric Critical Care, University of Missouri, Columbia, Missouri
| |
Collapse
|
8
|
Sessions KL, Smith AG, Holmberg PJ, Wahl B, Mvalo T, Chisti MJ, Carroll RW, McCollum ED. Continuous positive airway pressure for children in resource-limited settings, effect on mortality and adverse events: systematic review and meta-analysis. Arch Dis Child 2022; 107:543-552. [PMID: 34880003 PMCID: PMC9125374 DOI: 10.1136/archdischild-2021-323041] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Accepted: 11/17/2021] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Determine non-invasive ventilation with continuous positive airway pressure (CPAP) outcomes for paediatric respiratory distress in low-income and middle-income countries (LMICs). DESIGN Systematic review and meta-analysis. SETTING LMIC hospitals. PATIENTS One month to 15 year olds with respiratory distress. INTERVENTIONS We searched Medline, Embase, LILACS, Web of Science and Scopus on 7 April 2020. Included studies assessed CPAP safety, efficacy or effectiveness. All study types were included; neonatal only studies were excluded. Data were extracted by two reviewers and bias was assessed. Certainty of evidence was evaluated, and risk ratios (RR) were produced for meta-analyses. (PROSPERO protocol CRD42018084278). RESULTS 2174 papers were screened, 20 were included in the systematic review and 3 were included in two separate meta-analyses of mortality and adverse events. Studies suitable for meta-analysis were randomised controlled trials (RCTs) from Bangladesh, Ghana and Malawi. For meta-analyses comparing death or adverse events between CPAP and low-flow oxygen recipients, we found no clear CPAP effect on mortality (RR 0.75, 95% CI 0.33 to 1.72) or adverse events (RR 1.52, CI 0.71 to 3.26). We downgraded the certainty of evidence for both death and adverse events outcomes to 'low' due to design issues and results discrepancies across RCTs. CONCLUSIONS Evidence for CPAP efficacy against mortality and adverse events has low certainty and is context dependent. Hospitals introducing CPAP need to have mechanisms in place to optimise safety in the context it is being used; this includes the location (a high dependency or intensive care area), adequate numbers of staff trained in CPAP use, close monitoring and mechanisms for escalation, daily direct physician supervision, equipment that is age appropriate and user-friendly and continuous monitoring of outcomes and quality of care.
Collapse
Affiliation(s)
- Kristen L Sessions
- Department of Pediatrics, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
| | - Andrew G Smith
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA
| | - Peter J Holmberg
- Division of Pediatric Hospital Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic Children’s Center, Rochester, Minnesota, USA
| | - Brian Wahl
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Tisungane Mvalo
- University of North Carolina Project Malawi, Lilongwe, Malawi,Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA
| | - Mohammod J Chisti
- International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
| | - Ryan W Carroll
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, Mass General Hospital for Children, Harvard School of Medicine, Boston, Massachusetts, USA
| | - Eric D McCollum
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA .,Global Program in Pediatric Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
| |
Collapse
|
9
|
Eckerle M, Mvalo T, Smith AG, Kondowe D, Makonokaya D, Vaidya D, Hosseinipour MC, McCollum ED. Identifying modifiable risk factors for mortality in children aged 1-59 months admitted with WHO-defined severe pneumonia: a single-centre observational cohort study from rural Malawi. BMJ Paediatr Open 2022; 6:10.1136/bmjpo-2021-001330. [PMID: 36053605 PMCID: PMC9020281 DOI: 10.1136/bmjpo-2021-001330] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Accepted: 03/25/2022] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVE Although HIV infection, severe malnutrition and hypoxaemia are associated with high mortality in children with WHO-defined severe pneumonia in sub-Saharan Africa, many do not have these conditions and yet mortality remains elevated compared with high-resource settings. Further stratifying mortality risk for children without these conditions could permit more strategic resource utilisation and improved outcomes. We therefore evaluated associations between mortality and clinical characteristics not currently recognised by the WHO as high risk among children in Malawi with severe pneumonia but without HIV (including exposure), severe malnutrition and hypoxaemia. METHODS Between May 2016 and March 2018, we conducted a prospective observational study alongside a randomised controlled trial (CPAP IMPACT) at Salima District Hospital in Malawi. Children aged 1-59 months hospitalised with WHO-defined severe pneumonia without severe malnutrition, HIV and hypoxaemia were enrolled. Study staff assessed children at admission and ascertained hospital outcomes. We compared group characteristics using Student's t-test, rank-sum test, χ2 test or Fisher's exact test as appropriate. RESULTS Among 884 participants, grunting (10/112 (8.9%) vs 11/771 (1.4%)), stridor (2/14 (14.2%) vs 19/870 (2.1%)), haemoglobin <50 g/L (3/27 (11.1%) vs 18/857 (2.1%)) and malaria (11/204 (5.3%) vs 10/673 (1.4%)) were associated with mortality compared with children without these characteristics. Children who survived had a 22 g/L higher mean haemoglobin and 0.7 cm higher mean mid-upper arm circumference (MUAC) than those who died. CONCLUSION In this single-centre study, our analysis identifies potentially modifiable risk factors for mortality among hospitalised Malawian children with severe pneumonia: specific signs of respiratory distress (grunting, stridor), haemoglobin <50 g/L and malaria infection. Significant differences in mean haemoglobin and MUAC were observed between those who survived and those who died. These factors could further stratify mortality risk among hospitalised Malawian children with severe pneumonia lacking recognised high-risk conditions.
Collapse
Affiliation(s)
- Michelle Eckerle
- Division of Emergency Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Tisungane Mvalo
- University of North Carolina Project Malawi, Lilongwe, Central Region, Malawi.,Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Andrew G Smith
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA
| | - Davie Kondowe
- University of North Carolina Project Malawi, Lilongwe, Central Region, Malawi
| | - Don Makonokaya
- University of North Carolina Project Malawi, Lilongwe, Central Region, Malawi
| | - Dhananjay Vaidya
- Department of Pediatrics, BEAD Core, Johns Hopkins University, Baltimore, Maryland, USA
| | - Mina C Hosseinipour
- University of North Carolina Project Malawi, Lilongwe, Central Region, Malawi.,Division of Infectious Disease, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Eric D McCollum
- Global Program in Pediatric Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA .,Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
| |
Collapse
|
10
|
Russell RM, Bibollet-Ruche F, Liu W, Sherrill-Mix S, Li Y, Connell J, Loy DE, Trimboli S, Smith AG, Avitto AN, Gondim MVP, Plenderleith LJ, Wetzel KS, Collman RG, Ayouba A, Esteban A, Peeters M, Kohler WJ, Miller RA, François-Souquiere S, Switzer WM, Hirsch VM, Marx PA, Piel AK, Stewart FA, Georgiev AV, Sommer V, Bertolani P, Hart JA, Hart TB, Shaw GM, Sharp PM, Hahn BH. CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses. Proc Natl Acad Sci U S A 2021; 118:e2025914118. [PMID: 33771926 PMCID: PMC8020793 DOI: 10.1073/pnas.2025914118] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Infection with human and simian immunodeficiency viruses (HIV/SIV) requires binding of the viral envelope glycoprotein (Env) to the host protein CD4 on the surface of immune cells. Although invariant in humans, the Env binding domain of the chimpanzee CD4 is highly polymorphic, with nine coding variants circulating in wild populations. Here, we show that within-species CD4 diversity is not unique to chimpanzees but found in many African primate species. Characterizing the outermost (D1) domain of the CD4 protein in over 500 monkeys and apes, we found polymorphic residues in 24 of 29 primate species, with as many as 11 different coding variants identified within a single species. D1 domain amino acid replacements affected SIV Env-mediated cell entry in a single-round infection assay, restricting infection in a strain- and allele-specific fashion. Several identical CD4 polymorphisms, including the addition of N-linked glycosylation sites, were found in primate species from different genera, providing striking examples of parallel evolution. Moreover, seven different guenons (Cercopithecus spp.) shared multiple distinct D1 domain variants, pointing to long-term trans-specific polymorphism. These data indicate that the HIV/SIV Env binding region of the primate CD4 protein is highly variable, both within and between species, and suggest that this diversity has been maintained by balancing selection for millions of years, at least in part to confer protection against primate lentiviruses. Although long-term SIV-infected species have evolved specific mechanisms to avoid disease progression, primate lentiviruses are intrinsically pathogenic and have left their mark on the host genome.
Collapse
Affiliation(s)
- Ronnie M Russell
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | | | - Weimin Liu
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Scott Sherrill-Mix
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Yingying Li
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Jesse Connell
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Dorothy E Loy
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Stephanie Trimboli
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Andrew G Smith
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Alexa N Avitto
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Marcos V P Gondim
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Lindsey J Plenderleith
- Institute of Evolutionary Biology, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
- Centre for Immunity, Infection, and Evolution, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
| | - Katherine S Wetzel
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Ronald G Collman
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Ahidjo Ayouba
- Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090 Montpellier, France
| | - Amandine Esteban
- Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090 Montpellier, France
| | - Martine Peeters
- Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090 Montpellier, France
| | - William J Kohler
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109
| | - Richard A Miller
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109
| | | | - William M Switzer
- Laboratory Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329
| | - Vanessa M Hirsch
- Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892
| | - Preston A Marx
- Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70118
- Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433
| | - Alex K Piel
- Department of Anthropology, University College London, WC1H 0BW London, United Kingdom
| | - Fiona A Stewart
- Department of Anthropology, University College London, WC1H 0BW London, United Kingdom
- School of Biological and Environmental Sciences, Liverpool John Moores University, L3 3AF Liverpool, United Kingdom
| | - Alexander V Georgiev
- Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138
- School of Biological Sciences, Bangor University, LL57 2UW Bangor, United Kingdom
| | - Volker Sommer
- Department of Anthropology, University College London, WC1H 0BW London, United Kingdom
| | - Paco Bertolani
- Leverhulme Centre for Human Evolutionary Studies, University of Cambridge, CB2 1QH Cambridge, United Kingdom
| | - John A Hart
- Lukuru Wildlife Research Foundation, Tshuapa-Lomami-Lualaba Project, BP 2012, Kinshasa, Democratic Republic of the Congo
| | - Terese B Hart
- Lukuru Wildlife Research Foundation, Tshuapa-Lomami-Lualaba Project, BP 2012, Kinshasa, Democratic Republic of the Congo
| | - George M Shaw
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Paul M Sharp
- Institute of Evolutionary Biology, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
- Centre for Immunity, Infection, and Evolution, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
| | - Beatrice H Hahn
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| |
Collapse
|
11
|
Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, Li Y, Liu W, Avitto AN, DeVoto JC, Connell J, Fenton-May AE, Pellegrino P, Williams I, Papasavvas E, Lorenzi JCC, Salantes DB, Mampe F, Monroy MA, Cohen YZ, Heath S, Saag MS, Montaner LJ, Collman RG, Siliciano JM, Siliciano RF, Plenderleith LJ, Sharp PM, Caskey M, Nussenzweig MC, Shaw GM, Borrow P, Bar KJ, Hahn BH. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med 2021; 13:eabd8179. [PMID: 33441429 PMCID: PMC7923595 DOI: 10.1126/scitranslmed.abd8179] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 10/04/2020] [Accepted: 11/30/2020] [Indexed: 12/13/2022]
Abstract
Type 1 interferons (IFN-I) are potent innate antiviral effectors that constrain HIV-1 transmission. However, harnessing these cytokines for HIV-1 cure strategies has been hampered by an incomplete understanding of their antiviral activities at later stages of infection. Here, we characterized the IFN-I sensitivity of 500 clonally derived HIV-1 isolates from the plasma and CD4+ T cells of 26 individuals sampled longitudinally after transmission or after antiretroviral therapy (ART) and analytical treatment interruption. We determined the concentration of IFNα2 and IFNβ that reduced viral replication in vitro by 50% (IC50) and found consistent changes in the sensitivity of HIV-1 to IFN-I inhibition both across individuals and over time. Resistance of HIV-1 isolates to IFN-I was uniformly high during acute infection, decreased in all individuals in the first year after infection, was reacquired concomitant with CD4+ T cell loss, and remained elevated in individuals with accelerated disease. HIV-1 isolates obtained by viral outgrowth during suppressive ART were relatively IFN-I sensitive, resembling viruses circulating just before ART initiation. However, viruses that rebounded after treatment interruption displayed the highest degree of IFNα2 and IFNβ resistance observed at any time during the infection course. These findings indicate a dynamic interplay between host innate responses and the evolving HIV-1 quasispecies, with the relative contribution of IFN-I to HIV-1 control affected by both ART and analytical treatment interruption. Although elevated at transmission, host innate pressures are the highest during viral rebound, limiting the viruses that successfully become reactivated from latency to those that are IFN-I resistant.
Collapse
Affiliation(s)
- Marcos V P Gondim
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Scott Sherrill-Mix
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Frederic Bibollet-Ruche
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Ronnie M Russell
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | | | | | - Yingying Li
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Weimin Liu
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Alexa N Avitto
- Gene Therapy Program, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Julia C DeVoto
- Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA
| | - Jesse Connell
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | | | - Pierre Pellegrino
- Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London WC1E 6JB, UK
| | - Ian Williams
- Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London WC1E 6JB, UK
| | | | - Julio C C Lorenzi
- Laboratory of Molecular Immunology, Rockefeller University, New York, NY 10065, USA
| | | | - Felicity Mampe
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - M Alexandra Monroy
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | | | - Sonya Heath
- Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| | - Michael S Saag
- Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| | - Luis J Montaner
- Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA 19104, USA
| | - Ronald G Collman
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Janet M Siliciano
- Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
| | - Robert F Siliciano
- Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
- Howard Hughes Medical Institute, Johns Hopkins University, Baltimore, MD 21205, USA
| | - Lindsey J Plenderleith
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK
- Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK
| | - Paul M Sharp
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK
- Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK
| | - Marina Caskey
- Laboratory of Molecular Immunology, Rockefeller University, New York, NY 10065, USA
| | - Michel C Nussenzweig
- Laboratory of Molecular Immunology, Rockefeller University, New York, NY 10065, USA
- Howard Hughes Medical Institute, Rockefeller University, New York, NY 10065, USA
| | - George M Shaw
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Persephone Borrow
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK
| | - Katharine J Bar
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Beatrice H Hahn
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
| |
Collapse
|
12
|
Roark RS, Li H, Williams WB, Chug H, Mason RD, Gorman J, Wang S, Lee FH, Rando J, Bonsignori M, Hwang KK, Saunders KO, Wiehe K, Moody MA, Hraber PT, Wagh K, Giorgi EE, Russell RM, Bibollet-Ruche F, Liu W, Connell J, Smith AG, DeVoto J, Murphy AI, Smith J, Ding W, Zhao C, Chohan N, Okumura M, Rosario C, Ding Y, Lindemuth E, Bauer AM, Bar KJ, Ambrozak D, Chao CW, Chuang GY, Geng H, Lin BC, Louder MK, Nguyen R, Zhang B, Lewis MG, Raymond DD, Doria-Rose NA, Schramm CA, Douek DC, Roederer M, Kepler TB, Kelsoe G, Mascola JR, Kwong PD, Korber BT, Harrison SC, Haynes BF, Hahn BH, Shaw GM. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth. Science 2021; 371:eabd2638. [PMID: 33214287 PMCID: PMC8040783 DOI: 10.1126/science.abd2638] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Accepted: 11/09/2020] [Indexed: 12/21/2022]
Abstract
Neutralizing antibodies elicited by HIV-1 coevolve with viral envelope proteins (Env) in distinctive patterns, in some cases acquiring substantial breadth. We report that primary HIV-1 envelope proteins-when expressed by simian-human immunodeficiency viruses in rhesus macaques-elicited patterns of Env-antibody coevolution very similar to those in humans, including conserved immunogenetic, structural, and chemical solutions to epitope recognition and precise Env-amino acid substitutions, insertions, and deletions leading to virus persistence. The structure of one rhesus antibody, capable of neutralizing 49% of a 208-strain panel, revealed a V2 apex mode of recognition like that of human broadly neutralizing antibodies (bNAbs) PGT145 and PCT64-35S. Another rhesus antibody bound the CD4 binding site by CD4 mimicry, mirroring human bNAbs 8ANC131, CH235, and VRC01. Virus-antibody coevolution in macaques can thus recapitulate developmental features of human bNAbs, thereby guiding HIV-1 immunogen design.
Collapse
Affiliation(s)
- Ryan S Roark
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Hui Li
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Wilton B Williams
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
| | - Hema Chug
- Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA
| | - Rosemarie D Mason
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Jason Gorman
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Shuyi Wang
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Fang-Hua Lee
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Juliette Rando
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Mattia Bonsignori
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
| | - Kwan-Ki Hwang
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
| | - Kevin O Saunders
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Departments of Immunology and Surgery, Duke University School of Medicine, Durham, NC 27710, USA
| | - Kevin Wiehe
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
| | - M Anthony Moody
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Departments of Pediatrics and Immunology, Duke University School of Medicine, Durham, NC 27710, USA
| | - Peter T Hraber
- Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - Kshitij Wagh
- Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - Elena E Giorgi
- Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - Ronnie M Russell
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Frederic Bibollet-Ruche
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Weimin Liu
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Jesse Connell
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Andrew G Smith
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Julia DeVoto
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Alexander I Murphy
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Jessica Smith
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Wenge Ding
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Chengyan Zhao
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Neha Chohan
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Maho Okumura
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Christina Rosario
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Yu Ding
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Emily Lindemuth
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Anya M Bauer
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Katharine J Bar
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - David Ambrozak
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Cara W Chao
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Gwo-Yu Chuang
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Hui Geng
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Bob C Lin
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Mark K Louder
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Richard Nguyen
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Baoshan Zhang
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | | | - Donald D Raymond
- Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA
| | - Nicole A Doria-Rose
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Chaim A Schramm
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Daniel C Douek
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Mario Roederer
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Thomas B Kepler
- Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA
- Department of Mathematics and Statistics, Boston University, Boston, MA 02215, USA
| | - Garnett Kelsoe
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Departments of Immunology and Surgery, Duke University School of Medicine, Durham, NC 27710, USA
| | - John R Mascola
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Peter D Kwong
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Bette T Korber
- Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - Stephen C Harrison
- Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA
- Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA
| | - Barton F Haynes
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
| | - Beatrice H Hahn
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - George M Shaw
- Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
| |
Collapse
|
13
|
Guerrero C, Lerendegui-Marco J, Paul M, Tessler M, Heinitz S, Domingo-Pardo C, Cristallo S, Dressler R, Halfon S, Kivel N, Köster U, Maugeri EA, Palchan-Hazan T, Quesada JM, Rochman D, Schumann D, Weissman L, Aberle O, Amaducci S, Andrzejewski J, Audouin L, Bécares V, Bacak M, Balibrea J, Barak A, Barbagallo M, Barros S, Bečvář F, Beinrucker C, Berkovits D, Berthoumieux E, Billowes J, Bosnar D, Brugger M, Buzaglo Y, Caamaño M, Calviño F, Calviani M, Cano-Ott D, Cardella R, Casanovas A, Castelluccio DM, Cerutti F, Chen YH, Chiaveri E, Colonna N, Cortés G, Cortés-Giraldo MA, Cosentino L, Dafna H, Damone A, Diakaki M, Dietz M, Dupont E, Durán I, Eisen Y, Fernández-Domínguez B, Ferrari A, Ferreira P, Finocchiaro P, Furman V, Göbel K, García AR, Gawlik A, Glodariu T, Gonçalves IF, González-Romero E, Goverdovski A, Griesmayer E, Gunsing F, Harada H, Heftrich T, Heyse J, Hirsh T, Jenkins DG, Jericha E, Käppeler F, Kadi Y, Kaizer B, Katabuchi T, Kavrigin P, Ketlerov V, Khryachkov V, Kijel D, Kimura A, Kokkoris M, Kriesel A, Krtička M, Leal-Cidoncha E, Lederer-Woods C, Leeb H, Lo Meo S, Lonsdale SJ, Losito R, Macina D, Manna A, Marganiec J, Martínez T, Massimi C, Mastinu P, Mastromarco M, Matteucci F, Mendoza E, Mengoni A, Milazzo PM, Millán-Callado MA, Mingrone F, Mirea M, Montesano S, Musumarra A, Nolte R, Oprea A, Patronis N, Pavlik A, Perkowski J, Piersanti L, Porras I, Praena J, Rajeev K, Rauscher T, Reifarth R, Rodríguez-González T, Rout PC, Rubbia C, Ryan JA, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schmidt S, Shor A, Sedyshev P, Smith AG, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia A, Tassan-Got L, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vlachoudis V, Vlastou R, Wallner A, Warren S, Weigand M, Weiss C, Wolf C, Woods PJ, Wright T, Žugec P. Neutron Capture on the s-Process Branching Point ^{171}Tm via Time-of-Flight and Activation. Phys Rev Lett 2020; 125:142701. [PMID: 33064503 DOI: 10.1103/physrevlett.125.142701] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2017] [Revised: 07/02/2020] [Accepted: 07/29/2020] [Indexed: 06/11/2023]
Abstract
The neutron capture cross sections of several unstable nuclides acting as branching points in the s process are crucial for stellar nucleosynthesis studies. The unstable ^{171}Tm (t_{1/2}=1.92 yr) is part of the branching around mass A∼170 but its neutron capture cross section as a function of the neutron energy is not known to date. In this work, following the production for the first time of more than 5 mg of ^{171}Tm at the high-flux reactor Institut Laue-Langevin in France, a sample was produced at the Paul Scherrer Institute in Switzerland. Two complementary experiments were carried out at the neutron time-of-flight facility (n_TOF) at CERN in Switzerland and at the SARAF liquid lithium target facility at Soreq Nuclear Research Center in Israel by time of flight and activation, respectively. The result of the time-of-flight experiment consists of the first ever set of resonance parameters and the corresponding average resonance parameters, allowing us to make an estimation of the Maxwellian-averaged cross sections (MACS) by extrapolation. The activation measurement provides a direct and more precise measurement of the MACS at 30 keV: 384(40) mb, with which the estimation from the n_TOF data agree at the limit of 1 standard deviation. This value is 2.6 times lower than the JEFF-3.3 and ENDF/B-VIII evaluations, 25% lower than that of the Bao et al. compilation, and 1.6 times larger than the value recommended in the KADoNiS (v1) database, based on the only previous experiment. Our result affects the nucleosynthesis at the A∼170 branching, namely, the ^{171}Yb abundance increases in the material lost by asymptotic giant branch stars, providing a better match to the available pre-solar SiC grain measurements compared to the calculations based on the current JEFF-3.3 model-based evaluation.
Collapse
Affiliation(s)
- C Guerrero
- Universidad de Sevilla, Seville, Spain
- Centro Nacional de Aceleradores (CNA) (Universidad de Sevilla-Junta de Andalucía-CSIC), Seville, Spain
| | | | - M Paul
- Hebrew University, Jerusalem, Israel
| | - M Tessler
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - S Heinitz
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - C Domingo-Pardo
- Instituto de Física Corpuscular (CSIC-University of Valencia), Valencia, Spain
| | - S Cristallo
- INAF-Osservatorio Astronomico d'Abruzzo, Teramo, Italy
- INFN Sezione Perugia, Perugia, Italy
| | - R Dressler
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - S Halfon
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - N Kivel
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - U Köster
- Institut Laue-Langevin ILL, Grenoble, France
| | - E A Maugeri
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | | | | | - D Rochman
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - D Schumann
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - L Weissman
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - O Aberle
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Amaducci
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | | | - L Audouin
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, Orsay Cedex, France
| | - V Bécares
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - M Bacak
- Technische Universität Wien, Vienna, Austria
| | - J Balibrea
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Barak
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - M Barbagallo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - S Barros
- Instituto Superior Técnico, Lisbon, Portugal
| | - F Bečvář
- Charles University, Prague, Czech Republic
| | | | - D Berkovits
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - E Berthoumieux
- CEA Irfu, Université Paris-Saclay, Gif-sur-Yvette, France
| | - J Billowes
- University of Manchester, Manchester, United Kingdom
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - M Brugger
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Y Buzaglo
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - M Caamaño
- University of Santiago de Compostela, Santiago de Conpostela, Spain
| | - F Calviño
- Universitat Politècnica de Catalunya, Barcelona, Spain
| | - M Calviani
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Cano-Ott
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - R Cardella
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Casanovas
- Universitat Politècnica de Catalunya, Barcelona, Spain
| | - D M Castelluccio
- Agenzia nazionale per le nuove tecnologie (ENEA), Bologna, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - F Cerutti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Y H Chen
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, Orsay Cedex, France
| | - E Chiaveri
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - N Colonna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - G Cortés
- Universitat Politècnica de Catalunya, Barcelona, Spain
| | | | - L Cosentino
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | - H Dafna
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - A Damone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- Dipartimento di Fisica, Università degli Studi di Bari, Bari, Italy
| | - M Diakaki
- CEA Irfu, Université Paris-Saclay, Gif-sur-Yvette, France
| | - M Dietz
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - E Dupont
- CEA Irfu, Université Paris-Saclay, Gif-sur-Yvette, France
| | - I Durán
- University of Santiago de Compostela, Santiago de Conpostela, Spain
| | - Y Eisen
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | | | - A Ferrari
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Ferreira
- Instituto Superior Técnico, Lisbon, Portugal
| | | | - V Furman
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - K Göbel
- Goethe University Frankfurt, Seville, Germany
| | - A R García
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Gawlik
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - T Glodariu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Jerusalem, Romania
| | | | - E González-Romero
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Goverdovski
- Institute of Physics and Power Engineering (IPPE), Obninsk, Russia
| | | | - F Gunsing
- Institut Laue-Langevin ILL, Grenoble, France
- CEA Irfu, Université Paris-Saclay, Gif-sur-Yvette, France
| | - H Harada
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - T Heftrich
- Goethe University Frankfurt, Seville, Germany
| | - J Heyse
- Universitat Politècnica de Catalunya, Barcelona, Spain
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - T Hirsh
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | | | - E Jericha
- Technische Universität Wien, Vienna, Austria
| | - F Käppeler
- Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | - Y Kadi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Kaizer
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | | | - P Kavrigin
- Technische Universität Wien, Vienna, Austria
| | - V Ketlerov
- Institute of Physics and Power Engineering (IPPE), Obninsk, Russia
| | - V Khryachkov
- Institute of Physics and Power Engineering (IPPE), Obninsk, Russia
| | - D Kijel
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - A Kimura
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - M Kokkoris
- National Technical University of Athens, Athens, Greece
| | - A Kriesel
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - M Krtička
- Charles University, Prague, Czech Republic
| | - E Leal-Cidoncha
- University of Santiago de Compostela, Santiago de Conpostela, Spain
| | - C Lederer-Woods
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - H Leeb
- Technische Universität Wien, Vienna, Austria
| | - S Lo Meo
- Agenzia nazionale per le nuove tecnologie (ENEA), Bologna, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - S J Lonsdale
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - R Losito
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Macina
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Manna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Bologna, Italy
| | | | - T Martínez
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - C Massimi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Bologna, Italy
| | - P Mastinu
- Istituto Nazionale di Fisica Nucleare, Sezione di Legnaro, Italy
| | - M Mastromarco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - F Matteucci
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Italy
- Dipartimento di Astronomia, Università di Trieste, Trieste, Italy
| | - E Mendoza
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Mengoni
- Agenzia nazionale per le nuove tecnologie (ENEA), Bologna, Italy
| | - P M Milazzo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Italy
| | - M A Millán-Callado
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, Orsay Cedex, France
| | - F Mingrone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - M Mirea
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Jerusalem, Romania
| | - S Montesano
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Musumarra
- INFN Laboratori Nazionali del Sud, Catania, Italy
- Dipartimento di Fisica e Astronomia, Università di Catania, Catania, Italy
| | - R Nolte
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - A Oprea
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Jerusalem, Romania
| | - N Patronis
- University of Ioannina, Ioannina, Greece
| | - A Pavlik
- University of Vienna, Faculty of Physics, Vienna, Austria
| | | | - L Piersanti
- INAF-Osservatorio Astronomico d'Abruzzo, Teramo, Italy
| | - I Porras
- University of Granada, Granada, Spain
| | - J Praena
- Universidad de Sevilla, Seville, Spain
- University of Granada, Granada, Spain
| | - K Rajeev
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - T Rauscher
- Centre for Astrophysics Research, University of Hertfordshire, Hatfield, United Kingdom
- Department of Physics, University of Basel, Basel, Switzerland
| | - R Reifarth
- Goethe University Frankfurt, Seville, Germany
| | - T Rodríguez-González
- Universidad de Sevilla, Seville, Spain
- Centro Nacional de Aceleradores (CNA) (Universidad de Sevilla-Junta de Andalucía-CSIC), Seville, Spain
| | - P C Rout
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - C Rubbia
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J A Ryan
- University of Manchester, Manchester, United Kingdom
| | - M Sabaté-Gilarte
- Universidad de Sevilla, Seville, Spain
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Saxena
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | | | - S Schmidt
- Goethe University Frankfurt, Seville, Germany
| | - A Shor
- Soreq Nuclear Research Center (SNRC), Yavne, Israel
| | - P Sedyshev
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - A G Smith
- University of Manchester, Manchester, United Kingdom
| | | | - G Tagliente
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - J L Tain
- Instituto de Física Corpuscular (CSIC-University of Valencia), Valencia, Spain
| | | | - L Tassan-Got
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, Orsay Cedex, France
| | - A Tsinganis
- National Technical University of Athens, Athens, Greece
| | - S Valenta
- Charles University, Prague, Czech Republic
| | - G Vannini
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Bologna, Italy
| | - V Variale
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - P Vaz
- Instituto Superior Técnico, Lisbon, Portugal
| | - A Ventura
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - V Vlachoudis
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Vlastou
- National Technical University of Athens, Athens, Greece
| | - A Wallner
- Australian National University, Canberra, Australia
| | - S Warren
- University of Manchester, Manchester, United Kingdom
| | - M Weigand
- Goethe University Frankfurt, Seville, Germany
| | - C Weiss
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Technische Universität Wien, Vienna, Austria
| | - C Wolf
- Goethe University Frankfurt, Seville, Germany
| | - P J Woods
- School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
| | - T Wright
- University of Manchester, Manchester, United Kingdom
| | - P Žugec
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| |
Collapse
|
14
|
Paes W, Leonov G, Partridge T, Chikata T, Murakoshi H, Frangou A, Brackenridge S, Nicastri A, Smith AG, Learn GH, Li Y, Parker R, Oka S, Pellegrino P, Williams I, Haynes BF, McMichael AJ, Shaw GM, Hahn BH, Takiguchi M, Ternette N, Borrow P. Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8 + T cells in HIV-1 infection. Proc Natl Acad Sci U S A 2019; 116:24748-24759. [PMID: 31748275 PMCID: PMC6900506 DOI: 10.1073/pnas.1911622116] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Peptides generated by proteasome-catalyzed splicing of noncontiguous amino acid sequences have been shown to constitute a source of nontemplated human leukocyte antigen class I (HLA-I) epitopes, but their role in pathogen-specific immunity remains unknown. CD8+ T cells are key mediators of HIV type 1 (HIV-1) control, and identification of novel epitopes to enhance targeting of infected cells is a priority for prophylactic and therapeutic strategies. To explore the contribution of proteasome-catalyzed peptide splicing (PCPS) to HIV-1 epitope generation, we developed a broadly applicable mass spectrometry-based discovery workflow that we employed to identify spliced HLA-I-bound peptides on HIV-infected cells. We demonstrate that HIV-1-derived spliced peptides comprise a relatively minor component of the HLA-I-bound viral immunopeptidome. Although spliced HIV-1 peptides may elicit CD8+ T cell responses relatively infrequently during infection, CD8+ T cells primed by partially overlapping contiguous epitopes in HIV-infected individuals were able to cross-recognize spliced viral peptides, suggesting a potential role for PCPS in restricting HIV-1 escape pathways. Vaccine-mediated priming of responses to spliced HIV-1 epitopes could thus provide a novel means of exploiting epitope targets typically underutilized during natural infection.
Collapse
Affiliation(s)
- Wayne Paes
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom;
| | - German Leonov
- York Cross-Disciplinary Centre for Systems Analysis, University of York, York YO10 5DD, United Kingdom
| | - Thomas Partridge
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
| | - Takayuki Chikata
- Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
| | - Hayato Murakoshi
- Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
| | - Anna Frangou
- Big Data Institute, University of Oxford, Oxford OX3 7LF, United Kingdom
| | - Simon Brackenridge
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
| | - Annalisa Nicastri
- Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom
| | - Andrew G Smith
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Gerald H Learn
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Yingying Li
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Robert Parker
- Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom
| | - Shinichi Oka
- Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan
- AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo 162-8655, Japan
| | - Pierre Pellegrino
- Centre for Sexual Health and HIV Research, University College London, London WC1E 6JB, United Kingdom
| | - Ian Williams
- Centre for Sexual Health and HIV Research, University College London, London WC1E 6JB, United Kingdom
| | - Barton F Haynes
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710
| | - Andrew J McMichael
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
| | - George M Shaw
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Beatrice H Hahn
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | | | - Nicola Ternette
- Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom;
| | - Persephone Borrow
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom;
| |
Collapse
|
15
|
McCollum ED, Mvalo T, Eckerle M, Smith AG, Kondowe D, Makonokaya D, Vaidya D, Billioux V, Chalira A, Lufesi N, Mofolo I, Hosseinipour M. Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial. Lancet Respir Med 2019; 7:964-974. [PMID: 31562059 PMCID: PMC6838668 DOI: 10.1016/s2213-2600(19)30243-7] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/09/2019] [Revised: 07/08/2019] [Accepted: 07/09/2019] [Indexed: 12/14/2022]
Abstract
Background Pneumonia is the leading cause of death among children globally. Most pneumonia deaths in low-income and middle-income countries (LMICs) occur among children with HIV infection or exposure, severe malnutrition, or hypoxaemia despite antibiotics and oxygen. Non-invasive bubble continuous positive airway pressure (bCPAP) is considered a safe ventilation modality that might improve child pneumonia survival. bCPAP outcomes for high-risk African children with severe pneumonia are unknown. Since most child pneumonia hospitalisations in Africa occur in non-tertiary district hospitals without daily physician oversight, we aimed to examine whether bCPAP improves severe pneumonia mortality in such settings. Methods This open-label, randomised, controlled trial was done in the general paediatric ward of Salima District Hospital, Malawi. We enrolled children aged 1–59 months old with WHO-defined severe pneumonia and either HIV infection or exposure, severe malnutrition, or an oxygen saturation of less than 90%. Children were randomly assigned 1:1 to low-flow nasal cannula oxygen or nasal bCPAP. Non-physicians administered care; the primary outcome was hospital survival. Primary analyses were by intention-to-treat and interim and adverse events analyses per protocol. This trial is registered with ClinicalTrials.gov, number NCT02484183, and is closed. Findings We screened 1712 children for eligibility between June 23, 2015, and March 21, 2018. The data safety and monitoring board stopped the trial for futility after 644 of the intended 900 participants were enrolled. 323 children were randomly assigned to oxygen and 321 to bCPAP. 35 (11%) of 323 children who received oxygen died in hospital, as did 53 (17%) of 321 who received bCPAP (relative risk 1·52; 95% CI 1·02–2·27; p=0·036). 13 oxygen and 17 bCPAP patients lacked hospital outcomes and were considered lost to follow-up. Suspected adverse events related to treatment occurred in 11 (3%) of 321 children receiving bCPAP and 1 (<1%) of 323 children receiving oxygen. Four bCPAP and one oxygen group deaths were classified as probable aspiration episodes, one bCPAP death as probable pneumothorax, and six non-death bCPAP events included skin breakdown around the nares. Interpretation bCPAP treatment in a paediatric ward without daily physician supervision did not reduce hospital mortality among high-risk Malawian children with severe pneumonia, compared with oxygen. The use of bCPAP within certain patient populations and non-intensive care settings might carry risk that was not previously recognised. bCPAP in LMICs needs further evaluation before wider implementation for child pneumonia care. Funding Bill & Melinda Gates Foundation, International AIDS Society, Health Empowering Humanity.
Collapse
Affiliation(s)
- Eric D McCollum
- Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
| | - Tisungane Mvalo
- University of North Carolina Project Malawi, Lilongwe, Malawi; Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, NC, USA
| | - Michelle Eckerle
- Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
| | - Andrew G Smith
- University of Utah School of Medicine, Salt Lake City, UT, USA
| | - Davie Kondowe
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | - Don Makonokaya
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | | | | | | | | | - Innocent Mofolo
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | - Mina Hosseinipour
- University of North Carolina Project Malawi, Lilongwe, Malawi; Division of Infectious Disease, University of North Carolina at Chapel Hill, NC, USA
| |
Collapse
|
16
|
Sessions KL, Mvalo T, Kondowe D, Makonokaya D, Hosseinipour MC, Chalira A, Lufesi N, Eckerle M, Smith AG, McCollum ED. Bubble CPAP and oxygen for child pneumonia care in Malawi: a CPAP IMPACT time motion study. BMC Health Serv Res 2019; 19:533. [PMID: 31366394 PMCID: PMC6668155 DOI: 10.1186/s12913-019-4364-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2019] [Accepted: 07/22/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In some low-resource settings bubble continuous positive airway pressure (bCPAP) is increasingly used to treat children with pneumonia. However, the time required for healthcare workers (HCWs) to administer bCPAP is unknown and may have implementation implications. This study aims to compare HCW time spent administering bCPAP and low-flow nasal oxygen care at a district hospital in Malawi during CPAP IMPACT (Improving Mortality for Pneumonia in African Children Trial). METHODS Eligible participants were 1-59 months old with WHO-defined severe pneumonia and HIV-infection, HIV-exposure, severe malnutrition, or hypoxemia and were randomized to either bCPAP or oxygen. We used time motion techniques to observe hospital care in four hour blocks during treatment initiation or follow up (maintenance). HCW mean time per patient at the bedside over the observation period was calculated by study arm. RESULTS Overall, bCPAP required an average of 34.71 min per patient more than low-flow nasal oxygen to initiate (bCPAP, 118.18 min (standard deviation (SD) 42.73 min); oxygen, 83.47 min (SD, 20.18 min), p < 0.01). During initiation, HCWs spent, on average, 12.45 min longer per patient setting up bCPAP equipment (p < 0.01) and 11.13 min longer per patient setting up the bCPAP nasal interface (p < 0.01), compared to oxygen equipment and nasal cannula set-up. During maintenance care, HCWs spent longer on average per patient adjusting bCPAP, compared to oxygen equipment (bCPAP 4.57 min (SD, 4.78 min); oxygen, 1.52 min (SD, 2.50 min), p = 0.03). CONCLUSION Effective bCPAP implementation in low-resource settings will likely create additional HCW burden relative to usual pneumonia care with oxygen. TRIAL REGISTRATION Clinicaltrials.gov NCT02484183 , June 29, 2015.
Collapse
Affiliation(s)
- Kristen L. Sessions
- Mayo Clinic School of Medicine, 200 1st Street SW, Rochester, MN USA
- Northwestern University, Lurie Children’s Hospital, 225 E, Chicago, IL 60611 USA
| | - Tisungane Mvalo
- University of North Carolina Project Malawi, Tidziwe Centre, 100 Mzimba Road, Lilongwe, Malawi
| | - Davie Kondowe
- University of North Carolina Project Malawi, Tidziwe Centre, 100 Mzimba Road, Lilongwe, Malawi
| | - Donnie Makonokaya
- University of North Carolina Project Malawi, Tidziwe Centre, 100 Mzimba Road, Lilongwe, Malawi
| | - Mina C. Hosseinipour
- University of North Carolina Project Malawi, Tidziwe Centre, 100 Mzimba Road, Lilongwe, Malawi
| | - Alfred Chalira
- Community Health Science Unit, Private Bag, 65 Lilongwe, Malawi
| | - Norman Lufesi
- Community Health Science Unit, Private Bag, 65 Lilongwe, Malawi
| | - Michelle Eckerle
- University of Cincinnati College of Medicine, 3333 Burnet Ave, Cincinnati, OH 45229 USA
| | - Andrew G. Smith
- University of Utah, P.O. Box 581289, Salt Lake City, UT 84158 USA
| | - Eric D. McCollum
- Johns Hopkins School of Medicine, Rubenstein Child Health Building, #3150, 200 North Wolfe Street, Baltimore, MD 21287 USA
| |
Collapse
|
17
|
Heathcote LC, Allen JM, Gunn KM, Fox S, Harvie DS, Olver I, Skinner IW, Smith AG, Stanton TR, Whitford HS, Moseley GL. Pain Education for Adolescents and Young Adults Living Beyond Cancer: An Interdisciplinary Meeting Report. J Adolesc Young Adult Oncol 2019; 8:529-533. [PMID: 31150299 DOI: 10.1089/jayao.2019.0047] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Pain is an understudied and undertreated consequence of cancer survival. Pain education is now a recommended treatment approach for persistent non-cancer pain, yet it has not been well applied to the context of adolescent and young adult (AYA) cancer survival. In March 2018, an interdisciplinary meeting was held in Adelaide, South Australia to set a research agenda for pain education in AYA cancer survivors. We identified that AYAs with persistent pain and those with heightened pain-related fear have the potential to benefit from pain education. We identified a number of unique challenges of engaging AYA survivors in pain education, and point towards future research directions.
Collapse
Affiliation(s)
- Lauren C Heathcote
- Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University Medical School, Stanford, California
| | - Julie M Allen
- The Pentimento Project, Tarragindi, Queensland, Australia
| | - Kate M Gunn
- School of Health Sciences/University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia
| | - Simonie Fox
- AIA Australia, Sydney, New South Wales, Australia
| | - Daniel S Harvie
- The Hopkins Centre, Menzies Health Institute QLD, Griffith University, Gold Coast, Queensland, Australia.,School of Allied Health Sciences, Griffith University, Gold Coast, Queensland, Australia
| | - Ian Olver
- School of Health Sciences/University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia
| | - Ian W Skinner
- Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia
| | - Andrew G Smith
- Leukaemia Foundation of Australia, Melbourne, Victoria, Australia
| | - Tasha R Stanton
- School of Health Sciences/University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia.,Neuroscience Research Australia, Sydney, Australia
| | - Hayley S Whitford
- School of Health Sciences/University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia
| | - G Lorimer Moseley
- School of Health Sciences/University of South Australia Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia.,Neuroscience Research Australia, Sydney, Australia
| |
Collapse
|
18
|
Bibollet-Ruche F, Russell RM, Liu W, Stewart-Jones GBE, Sherrill-Mix S, Li Y, Learn GH, Smith AG, Gondim MVP, Plenderleith LJ, Decker JM, Easlick JL, Wetzel KS, Collman RG, Ding S, Finzi A, Ayouba A, Peeters M, Leendertz FH, van Schijndel J, Goedmakers A, Ton E, Boesch C, Kuehl H, Arandjelovic M, Dieguez P, Murai M, Colin C, Koops K, Speede S, Gonder MK, Muller MN, Sanz CM, Morgan DB, Atencia R, Cox D, Piel AK, Stewart FA, Ndjango JBN, Mjungu D, Lonsdorf EV, Pusey AE, Kwong PD, Sharp PM, Shaw GM, Hahn BH. CD4 receptor diversity in chimpanzees protects against SIV infection. Proc Natl Acad Sci U S A 2019; 116:3229-3238. [PMID: 30718403 PMCID: PMC6386711 DOI: 10.1073/pnas.1821197116] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Human and simian immunodeficiency viruses (HIV/SIVs) use CD4 as the primary receptor to enter target cells. Here, we show that the chimpanzee CD4 is highly polymorphic, with nine coding variants present in wild populations, and that this diversity interferes with SIV envelope (Env)-CD4 interactions. Testing the replication fitness of SIVcpz strains in CD4+ T cells from captive chimpanzees, we found that certain viruses were unable to infect cells from certain hosts. These differences were recapitulated in CD4 transfection assays, which revealed a strong association between CD4 genotypes and SIVcpz infection phenotypes. The most striking differences were observed for three substitutions (Q25R, Q40R, and P68T), with P68T generating a second N-linked glycosylation site (N66) in addition to an invariant N32 encoded by all chimpanzee CD4 alleles. In silico modeling and site-directed mutagenesis identified charged residues at the CD4-Env interface and clashes between CD4- and Env-encoded glycans as mechanisms of inhibition. CD4 polymorphisms also reduced Env-mediated cell entry of monkey SIVs, which was dependent on at least one D1 domain glycan. CD4 allele frequencies varied among wild chimpanzees, with high diversity in all but the western subspecies, which appeared to have undergone a selective sweep. One allele was associated with lower SIVcpz prevalence rates in the wild. These results indicate that substitutions in the D1 domain of the chimpanzee CD4 can prevent SIV cell entry. Although some SIVcpz strains have adapted to utilize these variants, CD4 diversity is maintained, protecting chimpanzees against infection with SIVcpz and other SIVs to which they are exposed.
Collapse
Affiliation(s)
| | - Ronnie M Russell
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Weimin Liu
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Guillaume B E Stewart-Jones
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
| | - Scott Sherrill-Mix
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Yingying Li
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Gerald H Learn
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Andrew G Smith
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Marcos V P Gondim
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Lindsey J Plenderleith
- Institute of Evolutionary Biology, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
- Centre for Immunity, Infection and Evolution, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
| | - Julie M Decker
- Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Juliet L Easlick
- Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
| | - Katherine S Wetzel
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Ronald G Collman
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Shilei Ding
- Département de Microbiologie, Infectiologie et Immunologie, Centre de Recherche du Centre Hospitalier de L'Université de Montréal, Montréal, QC H2X0A9, Canada
- Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC H2X0A9, Canada
| | - Andrés Finzi
- Département de Microbiologie, Infectiologie et Immunologie, Centre de Recherche du Centre Hospitalier de L'Université de Montréal, Montréal, QC H2X0A9, Canada
- Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC H2X0A9, Canada
| | - Ahidjo Ayouba
- Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090 Montpellier, France
| | - Martine Peeters
- Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, Institut de Recherche pour le Développement, University of Montpellier, INSERM, 34090 Montpellier, France
| | - Fabian H Leendertz
- Research Group Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany
| | - Joost van Schijndel
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
- Chimbo Foundation, 1011 PW Amsterdam, The Netherlands
| | | | - Els Ton
- Chimbo Foundation, 1011 PW Amsterdam, The Netherlands
| | - Christophe Boesch
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
| | - Hjalmar Kuehl
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
| | - Mimi Arandjelovic
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
| | - Paula Dieguez
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
| | - Mizuki Murai
- Department of Primatology, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany
| | - Christelle Colin
- Projet Primates France, Centre de Conservation pour Chimpanzés, BP 36 Faranah, Republic of Guinea
| | - Kathelijne Koops
- Department of Anthropology, University of Zurich, CH-8006 Zurich, Switzerland
| | - Sheri Speede
- Sanaga-Yong Chimpanzee Rescue Center, In Defense of Animals-Africa, Portland, OR 97204
| | - Mary K Gonder
- Department of Biology, Drexel University, Philadelphia, PA 19104
| | - Martin N Muller
- Department of Anthropology, University of New Mexico, Albuquerque, NM 87131
| | - Crickette M Sanz
- Department of Anthropology, Washington University in St. Louis, St Louis, MO 63130
- Congo Program, Wildlife Conservation Society, BP 14537 Brazzaville, Republic of the Congo
| | - David B Morgan
- Congo Program, Wildlife Conservation Society, BP 14537 Brazzaville, Republic of the Congo
- Lester E. Fisher Center for the Study and Conservation of Apes, Lincoln Park Zoo, Chicago, IL 60614
| | - Rebecca Atencia
- Tchimpounga Chimpanzee Rehabilitation Center, The Jane Goodall Institute-Congo, BP 1206 Pointe Noire, Republic of Congo
| | - Debby Cox
- Tchimpounga Chimpanzee Rehabilitation Center, The Jane Goodall Institute-Congo, BP 1206 Pointe Noire, Republic of Congo
- Africa Programs, The Jane Goodall Institute, Vienna, VA 22182
| | - Alex K Piel
- School of Natural Sciences and Psychology, Liverpool John Moores University, L3 3AF Liverpool, United Kingdom
| | - Fiona A Stewart
- School of Natural Sciences and Psychology, Liverpool John Moores University, L3 3AF Liverpool, United Kingdom
| | - Jean-Bosco N Ndjango
- Department of Ecology and Management of Plant and Animal Resources, Faculty of Sciences, University of Kisangani, BP 2012 Kisangani, Democratic Republic of the Congo
| | - Deus Mjungu
- Gombe Stream Research Centre, The Jane Goodall Institute, Kigoma, Tanzania
| | | | - Anne E Pusey
- Department of Evolutionary Anthropology, Duke University, Durham, NC 27708
| | - Peter D Kwong
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
| | - Paul M Sharp
- Institute of Evolutionary Biology, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
- Centre for Immunity, Infection and Evolution, University of Edinburgh, EH9 3FL Edinburgh, United Kingdom
| | - George M Shaw
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| | - Beatrice H Hahn
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
- Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104
| |
Collapse
|
19
|
Bennett EE, Hummel K, Smith AG, Longo N. Acute Presentation and Management of the Encephalopathic Child With an Undiagnosed Inborn Error of Metabolism. J Emerg Med 2018; 56:e5-e8. [PMID: 30420308 DOI: 10.1016/j.jemermed.2018.09.037] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2018] [Revised: 08/20/2018] [Accepted: 09/20/2018] [Indexed: 12/25/2022]
Abstract
BACKGROUND Inborn errors of metabolism (IEM) commonly present in infancy and, less commonly, later in life. CASE REPORT This case describes an IEM, specifically, ornithine transcarbamylase deficiency, in a previously healthy 7-year-old boy who presented to an emergency department with vomiting for approximately 24 h prior to admission. The child became progressively encephalopathic while in the emergency department, but an ammonia level was not obtained until several hours after admission. Irreversible brain damage with cerebral edema was already present at time of diagnosis, leading to death. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: This case emphasizes that acute hyperammonemia can rapidly cause irreversible neurological damage and, in the case of a newly encephalopathic pediatric patient, ammonia levels should be evaluated early to facilitate proper diagnostic tests and treatment.
Collapse
|
20
|
Barbian HJ, Connell AJ, Avitto AN, Russell RM, Smith AG, Gundlapally MS, Shazad AL, Li Y, Bibollet‐Ruche F, Wroblewski EE, Mjungu D, Lonsdorf EV, Stewart FA, Piel AK, Pusey AE, Sharp PM, Hahn BH. CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 2018; 8:7946-7963. [PMID: 30250675 PMCID: PMC6145012 DOI: 10.1002/ece3.4302] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 05/14/2018] [Accepted: 05/29/2018] [Indexed: 12/29/2022] Open
Abstract
Short tandem repeats (STRs), also known as microsatellites, are commonly used to noninvasively genotype wild-living endangered species, including African apes. Until recently, capillary electrophoresis has been the method of choice to determine the length of polymorphic STR loci. However, this technique is labor intensive, difficult to compare across platforms, and notoriously imprecise. Here we developed a MiSeq-based approach and tested its performance using previously genotyped fecal samples from long-term studied chimpanzees in Gombe National Park, Tanzania. Using data from eight microsatellite loci as a reference, we designed a bioinformatics platform that converts raw MiSeq reads into locus-specific files and automatically calls alleles after filtering stutter sequences and other PCR artifacts. Applying this method to the entire Gombe population, we confirmed previously reported genotypes, but also identified 31 new alleles that had been missed due to sequence differences and size homoplasy. The new genotypes, which increased the allelic diversity and heterozygosity in Gombe by 61% and 8%, respectively, were validated by replicate amplification and pedigree analyses. This demonstrated inheritance and resolved one case of an ambiguous paternity. Using both singleplex and multiplex locus amplification, we also genotyped fecal samples from chimpanzees in the Greater Mahale Ecosystem in Tanzania, demonstrating the utility of the MiSeq-based approach for genotyping nonhabituated populations and performing comparative analyses across field sites. The new automated high-throughput analysis platform (available at https://github.com/ShawHahnLab/chiimp) will allow biologists to more accurately and effectively determine wildlife population size and structure, and thus obtain information critical for conservation efforts.
Collapse
Affiliation(s)
- Hannah J. Barbian
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Andrew Jesse Connell
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Alexa N. Avitto
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Ronnie M. Russell
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Andrew G. Smith
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Madhurima S. Gundlapally
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Alexander L. Shazad
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Yingying Li
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Frederic Bibollet‐Ruche
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Emily E. Wroblewski
- Department of AnthropologyWashington University in St. LouisSt. LouisMissouri
| | | | | | - Fiona A. Stewart
- School of Natural Sciences and PsychologyLiverpool John Moores UniversityLiverpoolUK
| | - Alexander K. Piel
- School of Natural Sciences and PsychologyLiverpool John Moores UniversityLiverpoolUK
| | - Anne E. Pusey
- Department of Evolutionary AnthropologyDuke UniversityDurhamNorth Carolina
| | - Paul M. Sharp
- Institute of Evolutionary Biology and Centre for ImmunityInfection and EvolutionUniversity of EdinburghEdinburghUK
| | - Beatrice H. Hahn
- Departments of Microbiology and MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvania
| |
Collapse
|
21
|
Damone L, Barbagallo M, Mastromarco M, Mengoni A, Cosentino L, Maugeri E, Heinitz S, Schumann D, Dressler R, Käppeler F, Colonna N, Finocchiaro P, Andrzejewski J, Perkowski J, Gawlik A, Aberle O, Altstadt S, Ayranov M, Audouin L, Bacak M, Balibrea-Correa J, Ballof J, Bécares V, Bečvář F, Beinrucker C, Bellia G, Bernardes AP, Berthoumieux E, Billowes J, Borge MJG, Bosnar D, Brown A, Brugger M, Busso M, Caamaño M, Calviño F, Calviani M, Cano-Ott D, Cardella R, Casanovas A, Castelluccio DM, Catherall R, Cerutti F, Chen YH, Chiaveri E, Correia JGM, Cortés G, Cortés-Giraldo MA, Cristallo S, Diakaki M, Dietz M, Domingo-Pardo C, Dorsival A, Dupont E, Duran I, Fernandez-Dominguez B, Ferrari A, Ferreira P, Furman W, Ganesan S, García-Rios A, Gilardoni S, Glodariu T, Göbel K, Gonçalves IF, González-Romero E, Goodacre TD, Griesmayer E, Guerrero C, Gunsing F, Harada H, Heftrich T, Heyse J, Jenkins DG, Jericha E, Johnston K, Kadi Y, Kalamara A, Katabuchi T, Kavrigin P, Kimura A, Kivel N, Köster U, Kokkoris M, Krtička M, Kurtulgil D, Leal-Cidoncha E, Lederer-Woods C, Leeb H, Lerendegui-Marco J, Lo Meo S, Lonsdale SJ, Losito R, Macina D, Marganiec J, Marsh B, Martínez T, Masi A, Massimi C, Mastinu P, Matteucci F, Mazzone A, Mendoza E, Milazzo PM, Mingrone F, Mirea M, Musumarra A, Negret A, Nolte R, Oprea A, Patronis N, Pavlik A, Piersanti L, Piscopo M, Plompen A, Porras I, Praena J, Quesada JM, Radeck D, Rajeev K, Rauscher T, Reifarth R, Riego-Perez A, Rothe S, Rout P, Rubbia C, Ryan J, Sabaté-Gilarte M, Saxena A, Schell J, Schillebeeckx P, Schmidt S, Sedyshev P, Seiffert C, Smith AG, Sosnin NV, Stamatopoulos A, Stora T, Tagliente G, Tain JL, Tarifeño-Saldivia A, Tassan-Got L, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vlachoudis V, Vlastou R, Wallner A, Warren S, Weigand M, Weiß C, Wolf C, Woods PJ, Wright T, Žugec P. ^{7}Be(n,p)^{7}Li Reaction and the Cosmological Lithium Problem: Measurement of the Cross Section in a Wide Energy Range at n_TOF at CERN. Phys Rev Lett 2018; 121:042701. [PMID: 30095928 DOI: 10.1103/physrevlett.121.042701] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/16/2018] [Revised: 05/09/2018] [Indexed: 06/08/2023]
Abstract
We report on the measurement of the ^{7}Be(n,p)^{7}Li cross section from thermal to approximately 325 keV neutron energy, performed in the high-flux experimental area (EAR2) of the n_TOF facility at CERN. This reaction plays a key role in the lithium yield of the big bang nucleosynthesis (BBN) for standard cosmology. The only two previous time-of-flight measurements performed on this reaction did not cover the energy window of interest for BBN, and they showed a large discrepancy between each other. The measurement was performed with a Si telescope and a high-purity sample produced by implantation of a ^{7}Be ion beam at the ISOLDE facility at CERN. While a significantly higher cross section is found at low energy, relative to current evaluations, in the region of BBN interest, the present results are consistent with the values inferred from the time-reversal ^{7}Li(p,n)^{7}Be reaction, thus yielding only a relatively minor improvement on the so-called cosmological lithium problem. The relevance of these results on the near-threshold neutron production in the p+^{7}Li reaction is also discussed.
Collapse
Affiliation(s)
- L Damone
- INFN, Sezione di Bari, Italy
- Dipartimento di Fisica, Università degli Studi di Bari, Italy
| | - M Barbagallo
- INFN, Sezione di Bari, Italy
- European Organization for Nuclear Research (CERN), Switzerland
| | - M Mastromarco
- INFN, Sezione di Bari, Italy
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Mengoni
- ENEA, Bologna, Italy
- INFN, Sezione di Bologna, Italy
| | - L Cosentino
- INFN, Laboratori Nazionali del Sud, Catania, Italy
| | - E Maugeri
- Paul Scherrer Institut, Villigen PSI, Switzerland
| | - S Heinitz
- Paul Scherrer Institut, Villigen PSI, Switzerland
| | - D Schumann
- Paul Scherrer Institut, Villigen PSI, Switzerland
| | - R Dressler
- Paul Scherrer Institut, Villigen PSI, Switzerland
| | - F Käppeler
- Karlsruhe Institute of Technology (KIT), Institut für Kernphysik, Karlsruhe, Germany
| | | | | | | | | | - A Gawlik
- Uniwersytet Łódzki, Lodz, Poland
| | - O Aberle
- European Organization for Nuclear Research (CERN), Switzerland
| | - S Altstadt
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - M Ayranov
- European Commission, DG-Energy, Luxembourg
| | - L Audouin
- Centre National de la Recherche Scientifique/IN2P3, IPN, Orsay, France
| | - M Bacak
- European Organization for Nuclear Research (CERN), Switzerland
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | - J Balibrea-Correa
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - J Ballof
- European Organization for Nuclear Research (CERN), Switzerland
| | - V Bécares
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - F Bečvář
- Charles University, Prague, Czech Republic
| | - C Beinrucker
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - G Bellia
- INFN, Laboratori Nazionali del Sud, Catania, Italy
- Dipartimento di Fisica e Astronomia, Università di Catania, Italy
| | - A P Bernardes
- European Organization for Nuclear Research (CERN), Switzerland
| | | | - J Billowes
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - M J G Borge
- European Organization for Nuclear Research (CERN), Switzerland
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Croatia
| | - A Brown
- University of York, Heslington, York, United Kingdom
| | - M Brugger
- European Organization for Nuclear Research (CERN), Switzerland
| | - M Busso
- INFN, Sezione di Perugia, Italy
- Dipartimento di Fisica e Geologia, Università di Perugia, Italy
| | - M Caamaño
- Universidade de Santiago de Compostela, Spain
| | - F Calviño
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | - M Calviani
- European Organization for Nuclear Research (CERN), Switzerland
| | - D Cano-Ott
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - R Cardella
- European Organization for Nuclear Research (CERN), Switzerland
- INFN, Laboratori Nazionali del Sud, Catania, Italy
| | - A Casanovas
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | | | - R Catherall
- European Organization for Nuclear Research (CERN), Switzerland
| | - F Cerutti
- European Organization for Nuclear Research (CERN), Switzerland
| | - Y H Chen
- Centre National de la Recherche Scientifique/IN2P3, IPN, Orsay, France
| | - E Chiaveri
- European Organization for Nuclear Research (CERN), Switzerland
| | - J G M Correia
- European Organization for Nuclear Research (CERN), Switzerland
- C2TN, Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal
| | - G Cortés
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | | | - S Cristallo
- INFN, Sezione di Perugia, Italy
- Istituto Nazionale di Astrofisica, Osservatorio Astronomico d'Abruzzo, Italy
| | - M Diakaki
- National Technical University of Athens (NTUA), Greece
| | - M Dietz
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC, Universidad de Valencia, Spain
| | - A Dorsival
- European Organization for Nuclear Research (CERN), Switzerland
| | - E Dupont
- CEA/Saclay, IRFU, Gif-sur-Yvette, France
| | - I Duran
- Universidade de Santiago de Compostela, Spain
| | | | - A Ferrari
- European Organization for Nuclear Research (CERN), Switzerland
| | - P Ferreira
- C2TN, Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal
| | - W Furman
- Joint Institute of Nuclear Research, Dubna, Russia
| | - S Ganesan
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - A García-Rios
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - S Gilardoni
- European Organization for Nuclear Research (CERN), Switzerland
| | - T Glodariu
- Horia Hulubei National Institute for Physics and Nuclear Engineering (IFIN-HH), Bucharest-Magurele, Romania
| | - K Göbel
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - I F Gonçalves
- C2TN, Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal
| | - E González-Romero
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - T D Goodacre
- European Organization for Nuclear Research (CERN), Switzerland
| | - E Griesmayer
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | | | - F Gunsing
- CEA/Saclay, IRFU, Gif-sur-Yvette, France
| | - H Harada
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - T Heftrich
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - J Heyse
- European Commission JRC, Institute for Reference Materials and Measurements, Geel, Belgium
| | - D G Jenkins
- University of York, Heslington, York, United Kingdom
| | - E Jericha
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | - K Johnston
- European Organization for Nuclear Research (CERN), Switzerland
| | - Y Kadi
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Kalamara
- National Technical University of Athens (NTUA), Greece
| | | | - P Kavrigin
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | - A Kimura
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - N Kivel
- Paul Scherrer Institut, Villigen PSI, Switzerland
| | - U Köster
- Institut Laue-Langevin (ILL), Grenoble, France
| | - M Kokkoris
- National Technical University of Athens (NTUA), Greece
| | - M Krtička
- Charles University, Prague, Czech Republic
| | - D Kurtulgil
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | | | - C Lederer-Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - H Leeb
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | | | - S Lo Meo
- ENEA, Bologna, Italy
- INFN, Sezione di Bologna, Italy
| | - S J Lonsdale
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - R Losito
- European Organization for Nuclear Research (CERN), Switzerland
| | - D Macina
- European Organization for Nuclear Research (CERN), Switzerland
| | | | - B Marsh
- European Organization for Nuclear Research (CERN), Switzerland
| | - T Martínez
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Masi
- European Organization for Nuclear Research (CERN), Switzerland
| | - C Massimi
- INFN, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - P Mastinu
- INFN, Laboratori Nazionali di Legnaro, Italy
| | - F Matteucci
- INFN, Sezione di Trieste, Italy
- Dipartimento di Astronomia, Università di Trieste, Italy
| | - A Mazzone
- INFN, Sezione di Bari, Italy
- CNR, IC, Bari, Italy
| | - E Mendoza
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | | | - F Mingrone
- European Organization for Nuclear Research (CERN), Switzerland
| | - M Mirea
- Horia Hulubei National Institute for Physics and Nuclear Engineering (IFIN-HH), Bucharest-Magurele, Romania
| | - A Musumarra
- INFN, Laboratori Nazionali del Sud, Catania, Italy
- Dipartimento di Fisica e Astronomia, Università di Catania, Italy
| | - A Negret
- Horia Hulubei National Institute for Physics and Nuclear Engineering (IFIN-HH), Bucharest-Magurele, Romania
| | - R Nolte
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - A Oprea
- Horia Hulubei National Institute for Physics and Nuclear Engineering (IFIN-HH), Bucharest-Magurele, Romania
| | | | - A Pavlik
- University of Vienna, Faculty of Physics, Austria
| | - L Piersanti
- INFN, Sezione di Perugia, Italy
- Istituto Nazionale di Astrofisica, Osservatorio Astronomico d'Abruzzo, Italy
| | - M Piscopo
- INFN, Laboratori Nazionali del Sud, Catania, Italy
| | - A Plompen
- European Commission JRC, Institute for Reference Materials and Measurements, Geel, Belgium
| | | | - J Praena
- Universidad de Sevilla, Spain
- Universidad de Granada, Spain
| | | | - D Radeck
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - K Rajeev
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - T Rauscher
- Centre for Astrophysics Research, School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, United Kingdom
| | - R Reifarth
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - A Riego-Perez
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | - S Rothe
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - P Rout
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - C Rubbia
- European Organization for Nuclear Research (CERN), Switzerland
| | - J Ryan
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - M Sabaté-Gilarte
- European Organization for Nuclear Research (CERN), Switzerland
- Universidad de Sevilla, Spain
| | - A Saxena
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - J Schell
- European Organization for Nuclear Research (CERN), Switzerland
- Institute for Materials Science and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Essen, Germany
| | - P Schillebeeckx
- European Commission JRC, Institute for Reference Materials and Measurements, Geel, Belgium
| | - S Schmidt
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - P Sedyshev
- Joint Institute of Nuclear Research, Dubna, Russia
| | - C Seiffert
- European Organization for Nuclear Research (CERN), Switzerland
| | - A G Smith
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - N V Sosnin
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | | | - T Stora
- European Organization for Nuclear Research (CERN), Switzerland
| | | | - J L Tain
- Instituto de Física Corpuscular, CSIC, Universidad de Valencia, Spain
| | - A Tarifeño-Saldivia
- Universitat Politecnica de Catalunya, Barcelona, Spain
- Instituto de Física Corpuscular, CSIC, Universidad de Valencia, Spain
| | - L Tassan-Got
- Centre National de la Recherche Scientifique/IN2P3, IPN, Orsay, France
| | - A Tsinganis
- European Organization for Nuclear Research (CERN), Switzerland
| | - S Valenta
- Charles University, Prague, Czech Republic
| | - G Vannini
- INFN, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | | | - P Vaz
- C2TN, Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Portugal
| | | | - V Vlachoudis
- European Organization for Nuclear Research (CERN), Switzerland
| | - R Vlastou
- National Technical University of Athens (NTUA), Greece
| | - A Wallner
- University of Vienna, Faculty of Physics, Austria
- Research School of Physics and Engineering, Australian National University, Canberra, Australia
| | - S Warren
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - M Weigand
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - C Weiß
- European Organization for Nuclear Research (CERN), Switzerland
| | - C Wolf
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - P J Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - T Wright
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - P Žugec
- Department of Physics, Faculty of Science, University of Zagreb, Croatia
| |
Collapse
|
22
|
Smith AG, Foster JR. The association between chemical-induced porphyria and hepatic cancer. Toxicol Res (Camb) 2018; 7:647-663. [PMID: 30090612 PMCID: PMC6060669 DOI: 10.1039/c8tx00019k] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 04/04/2018] [Indexed: 01/24/2023] Open
Abstract
The haem biosynthetic pathway is of fundamental importance for cellular metabolism both for the erythroid and nonerythroid tissues. There are several genetic variants of the pathway in the human population that cause dysfunction of one or other of the enzymes resulting in porphyrias of varying severity. Serious chronic hepatic and systemic diseases may result. Some of these can be precipitated by exposure to drugs including hormones, barbiturates and antibiotics, as well as alcohol and particular chlorinated aromatic chemicals. In experimental animals some of the steps of this pathway can also be severely disrupted by a variety of environmental chemicals, potential drugs and pesticides, especially in the liver, leading to the accumulation of uroporphyrins derived from the intermediate uroporphyrinogens or protoporphyrin IX, the immediate precursor of haem. With some of these chemicals this also leads to cholestasis and liver cell injury and eventually hepatic tumours. The review evaluates the available evidence linking hepatic porphyria with carcinogenesis in naturally occurring human genetic conditions and in chemically-induced porphyrias in laboratory animals. The existing data showing gender, strain, and species differences in sensitivity to the chemical-induced porphyrias, liver injury and liver tumours are discussed and the role that transgenically altered mouse models have played in defining the varying mechanisms. Finally, the review proposes a novel, unifying hypothesis linking the hepatotoxicity induced by the accumulation of various porphyrins, with the increased risk of developing hepatic cancer as a long term consequence.
Collapse
Affiliation(s)
- Andrew G Smith
- MRC Toxicology Unit , Hodgkin Building , University of Leicester , Lancaster Road , Leicester LE2 4UA , UK .
| | - John R Foster
- ToxPath Sciences Ltd , 1 Troutbeck Avenue , Congleton , Cheshire , CW12 4JA , UK
| |
Collapse
|
23
|
Amalfitano M, Fyfe B, Thomas SV, Egan KP, Xu M, Smith AG, Kaplan FS, Shore EM, Pignolo RJ. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings. Bone 2018; 109:56-60. [PMID: 29320714 DOI: 10.1016/j.bone.2018.01.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Accepted: 01/06/2018] [Indexed: 02/08/2023]
Abstract
Mesenteric heterotopic ossification (MHO) is very rare and occurs in mid- to late-adulthood, usually in the context of prior abdominal surgery. The mechanisms of MHO are unknown. Here we describe the case of a 72-year-old man with MHO. Standard histological staining revealed that MHO occurred through an endochondral process. By comparison to known mutations in genetic conditions of HO such as fibrodysplasia ossificans progressiva (FOP) and progressive osseous heteroplasia (POH), DNA sequencing analysis demonstrated the presence of a commonly occurring heterozygous synonymous polymorphism (c.690G>A; E230E) in the causative gene for FOP (ACVR1/ALK2). However, no frameshift, missense, or nonsense mutations in ACVR1, or in the causative gene for POH (GNAS), were found. Although genetic predisposition may play a role in MHO, our data suggest that mutations which occur in known hereditary conditions of HO are not the primary cause.
Collapse
Affiliation(s)
- Matthew Amalfitano
- Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Billie Fyfe
- Department of Pathology and Laboratory Medicine, Rutgers - Robert Wood Johnson Medical School, Department of Pathology and Laboratory Medicine, United States
| | - Sumi V Thomas
- Department of Pathology and Laboratory Medicine, Rutgers - Robert Wood Johnson Medical School, Department of Pathology and Laboratory Medicine, United States
| | - Kevin P Egan
- Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Meiqi Xu
- Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Center for Research in FOP and Related Disorders, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Andrew G Smith
- Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Frederick S Kaplan
- Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Center for Research in FOP and Related Disorders, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Eileen M Shore
- Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Center for Research in FOP and Related Disorders, University of Pennsylvania School of Medicine, Philadelphia, PA, United States; Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
| | - Robert J Pignolo
- Department of Medicine, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, United States.
| |
Collapse
|
24
|
Chhabra Y, Wong HY, Nikolajsen LF, Steinocher H, Papadopulos A, Tunny KA, Meunier FA, Smith AG, Kragelund BB, Brooks AJ, Waters MJ. A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene 2018; 37:489-501. [PMID: 28967904 PMCID: PMC5799715 DOI: 10.1038/onc.2017.352] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2017] [Revised: 08/13/2017] [Accepted: 08/16/2017] [Indexed: 02/07/2023]
Abstract
Both humans and mice lacking functional growth hormone (GH) receptors are known to be resistant to cancer. Further, autocrine GH has been reported to act as a cancer promoter. Here we present the first example of a variant of the GH receptor (GHR) associated with cancer promotion, in this case lung cancer. We show that the GHRP495T variant located in the receptor intracellular domain is able to prolong the GH signal in vitro using stably expressing mouse pro-B-cell and human lung cell lines. This is relevant because GH secretion is pulsatile, and extending the signal duration makes it resemble autocrine GH action. Signal duration for the activated GHR is primarily controlled by suppressor of cytokine signalling 2 (SOCS2), the substrate recognition component of the E3 protein ligase responsible for ubiquitinylation and degradation of the GHR. SOCS2 is induced by a GH pulse and we show that SOCS2 binding to the GHR is impaired by a threonine substitution at Pro 495. This results in decreased internalisation and degradation of the receptor evident in TIRF microscopy and by measurement of mature (surface) receptor expression. Mutational analysis showed that the residue at position 495 impairs SOCS2 binding only when a threonine is present, consistent with interference with the adjacent Thr494. The latter is key for SOCS2 binding, together with nearby Tyr487, which must be phosphorylated for SOCS2 binding. We also undertook nuclear magnetic resonance spectroscopy approach for structural comparison of the SOCS2 binding scaffold Ile455-Ser588, and concluded that this single substitution has altered the structure of the SOCS2 binding site. Importantly, we find that lung BEAS-2B cells expressing GHRP495T display increased expression of transcripts associated with tumour proliferation, epithelial-mesenchymal transition and metastases (TWIST1, SNAI2, EGFR, MYC and CCND1) at 2 h after a GH pulse. This is consistent with prolonged GH signalling acting to promote cancer progression in lung cancer.
Collapse
Affiliation(s)
- Y Chhabra
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
- The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia
| | - H Y Wong
- University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia
| | - L F Nikolajsen
- Structural Biology and NMR Laboratory (SBiNLab), Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | - H Steinocher
- Structural Biology and NMR Laboratory (SBiNLab), Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | - A Papadopulos
- The Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
| | - K A Tunny
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
- The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia
| | - F A Meunier
- The Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
| | - A G Smith
- School of Biomedical Sciences, Institute of Health and Biomedical Innovation at the Translational Research Institute, Queensland University of Technology, Woolloongabba, Queensland, Australia
| | - B B Kragelund
- Structural Biology and NMR Laboratory (SBiNLab), Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | - A J Brooks
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
- The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia
| | - M J Waters
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|
25
|
Spiegel MT, Hoogerbrugge A, Truksa S, Smith AG, Shuford KL, Klausmeyer KK, Farmer PJ. Synthesis of first row transition metal selenomaltol complexes. Dalton Trans 2018; 47:9030-9037. [DOI: 10.1039/c8dt01170b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Complexation of selenomaltol to transition metal ions promotes a zwitterionic resonance form.
Collapse
Affiliation(s)
| | | | - Shamus Truksa
- Department of Chemistry and Biochemistry
- Baylor University
- Waco
- USA
| | - Andrew G. Smith
- Department of Chemistry and Biochemistry
- Baylor University
- Waco
- USA
| | - Kevin L. Shuford
- Department of Chemistry and Biochemistry
- Baylor University
- Waco
- USA
| | | | | |
Collapse
|
26
|
McCollum ED, Smith AG, Eckerle M, Mvalo T, O'Brien KL, Baqui AH. CPAP treatment for children with pneumonia in low-resource settings. Lancet Respir Med 2017; 5:924-925. [PMID: 29133034 DOI: 10.1016/s2213-2600(17)30347-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2017] [Accepted: 09/04/2017] [Indexed: 01/08/2023]
Affiliation(s)
- Eric D McCollum
- Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Department of International Health, International Center for Maternal and Newborn Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, USA.
| | - Andrew G Smith
- Paediatric Critical Care Medicine, University of Utah, Salt Lake City, UT, USA
| | - Michelle Eckerle
- Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | | | - Katherine L O'Brien
- Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, USA
| | - Abdullah H Baqui
- Department of International Health, International Center for Maternal and Newborn Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, USA
| |
Collapse
|
27
|
Smith AG. A spatially structured metapopulation model within a stochastic environment. Math Biosci 2017; 291:46-55. [PMID: 28709974 DOI: 10.1016/j.mbs.2017.07.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2017] [Revised: 06/15/2017] [Accepted: 07/10/2017] [Indexed: 11/24/2022]
Abstract
Populations often exist, either by choice or by external pressure, in a fragmented way, referred to as a metapopulation. Typically, the dynamics accounted for within metapopulation models are assumed to be static. For example, patch occupancy models often assume that the colonisation and extinction rates do not change, while spatially structured models often assume that the rates of births, deaths and migrations do not depend on time. While some progress has been made when these dynamics are changing deterministically, less is known when the changes are stochastic. It can be quite common that the environment a population inhabits determines how these dynamics change over time. Changes to this environment can have a large impact on the survival probability of a population and such changes will often be stochastic. The typical metapopulation model allows for catastrophes that could eradicate most, if not all, individuals on an entire patch. It is this type of phenomenon that this article addresses. A Markov process is developed that models the number of individuals on each patch within a metapopulation. An approximation for the original model is presented in the form of a piecewise-deterministic Markov process and the approximation is analysed to present conditions for extinction.
Collapse
Affiliation(s)
- Andrew G Smith
- School of Mathematical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
| |
Collapse
|
28
|
Smith AG, Eckerle M, Mvalo T, Weir B, Martinson F, Chalira A, Lufesi N, Mofolo I, Hosseinipour M, McCollum ED. CPAP IMPACT: a protocol for a randomised trial of bubble continuous positive airway pressure versus standard care for high-risk children with severe pneumonia using adaptive design methods. BMJ Open Respir Res 2017; 4:e000195. [PMID: 28883928 PMCID: PMC5531309 DOI: 10.1136/bmjresp-2017-000195] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 05/16/2017] [Accepted: 06/09/2017] [Indexed: 01/24/2023] Open
Abstract
Introduction Pneumonia is a leading cause of mortality among children in low-resource settings. Mortality is greatest among children with high-risk conditions including HIV infection or exposure, severe malnutrition and/or severe hypoxaemia. WHO treatment recommendations include low-flow oxygen for children with severe pneumonia. Bubble continuous positive airway pressure (bCPAP) is a non-invasive support modality that provides positive end-expiratory pressure and oxygen. bCPAP is effective in the treatment of neonates in low-resource settings; its efficacy is unknown for high-risk children with severe pneumonia in low-resource settings. Methods and analysis CPAP IMPACT is a randomised clinical trial comparing bCPAP to low-flow oxygen in the treatment of severe pneumonia among high-risk children 1–59 months of age. High-risk children are stratified into two subgroups: (1) HIV infection or exposure and/or severe malnutrition; (2) severe hypoxaemia. The trial is being conducted in a Malawi district hospital and will enrol 900 participants. The primary outcome is in-hospital mortality rate of children treated with standard care as compared with bCPAP. Ethics and dissemination CPAP IMPACT has approval from the Institutional Review Boards of all investigators. An urgent need exists to determine whether bCPAP decreases mortality among high-risk children with severe pneumonia to inform resource utilisation in low-resource settings. Trial registration number NCT02484183; Pre-results.
Collapse
Affiliation(s)
- Andrew G Smith
- Paediatric Critical Care Medicine, University of Utah, Salt Lake City, Utah, USA
| | - Michelle Eckerle
- Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | | | - Brian Weir
- Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
| | | | | | | | | | - Mina Hosseinipour
- Division of Infectious Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Eric D McCollum
- Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.,Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
| |
Collapse
|
29
|
Garelius HKG, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJM, Hellström-Lindberg E. Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome. J Intern Med 2017; 281:284-299. [PMID: 27926979 PMCID: PMC5596334 DOI: 10.1111/joim.12579] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND The EUMDS registry is an unique prospective, longitudinal observational registry enrolling newly diagnosed patients with lower-risk myelodysplastic syndrome (MDS) from 17 European countries from both university hospitals and smaller regional hospitals. OBJECTIVE The aim of this study was to describe the usage and clinical impact of erythropoiesis-stimulating agents (ESAs) in 1696 patients enrolled between 2008 and 2014. METHODS The effects of ESAs on outcomes were assessed using proportional hazards models weighting observations by propensity to receive ESA treatment within a subset of anaemic patients with or without a regular transfusion need. RESULTS ESA treatment (median duration of 27.5 months, range 0-77 months) was administered to 773 patients (45.6%). Outcomes were assessed in 897 patients (484 ESA treated and 413 untreated). ESA treatment was associated with a nonsignificant survival benefit (HR 0.82, 95% CI: 0.65-1.04, P = 0.09); this benefit was larger amongst patients without prior transfusions (P = 0.07). Amongst 539 patients for whom response to ESA treatment could be defined, median time to first post-ESA treatment transfusion was 6.1 months (IQR: 4.3-15.9 months) in those transfused before ESA treatment compared to 23.3 months (IQR: 7.0-47.8 months) in patients without prior transfusions (HR 2.4, 95% CI: 1.7-3.3, P < 0.0001). Responding patients had a better prognosis in terms of a lower risk of death (HR 0.65, 95% CI: 0.45-0.893, P = 0.018), whereas there was no significant effect on the risk of progression to acute myeloid leukaemia (HR 0.71, 95% CI: 0.39-1.29, P = 0.27). CONCLUSION Appropriate use of ESAs can significantly delay the onset of a regular transfusion need in patients with lower-risk MDS.
Collapse
Affiliation(s)
- H K G Garelius
- Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - W T Johnston
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - A G Smith
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - S Park
- Clinique Universitaire d'hématologie, CHU de Grenoble, Université Grenoble, Grenoble, France
| | - L de Swart
- Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands
| | - P Fenaux
- Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris, France
| | - A Symeonidis
- Department of Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece
| | - G Sanz
- Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - J Čermák
- Department of Clinical Hematology, Institute of Hematology & Blood Transfusion, Praha, Czech Republic
| | - R Stauder
- Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
| | - L Malcovati
- Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - M Mittelman
- Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel
| | - A A van de Loosdrecht
- Department of Hematology, VU Institute of Cancer and Immunology, VU University Medical Center, Amsterdam, the Netherlands
| | - C J van Marrewijk
- Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands
| | - D Bowen
- St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK
| | - S Crouch
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - T J M de Witte
- Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands
| | - E Hellström-Lindberg
- Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
30
|
Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, Learn GH, Plenderleith L, Smith AG, Barbian HJ, Russell RM, Gondim MVP, Bahari CY, Shaw CM, Li Y, Decker T, Haynes BF, Shaw GM, Sharp PM, Borrow P, Hahn BH. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci U S A 2017; 114:E590-E599. [PMID: 28069935 PMCID: PMC5278458 DOI: 10.1073/pnas.1620144114] [Citation(s) in RCA: 107] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Sexual transmission of HIV-1 is an inefficient process, with only one or few variants of the donor quasispecies establishing the new infection. A critical, and as yet unresolved, question is whether the mucosal bottleneck selects for viruses with increased transmission fitness. Here, we characterized 300 limiting dilution-derived virus isolates from the plasma, and in some instances genital secretions, of eight HIV-1 donor and recipient pairs. Although there were no differences in the amount of virion-associated envelope glycoprotein, recipient isolates were on average threefold more infectious (P = 0.0001), replicated to 1.4-fold higher titers (P = 0.004), were released from infected cells 4.2-fold more efficiently (P < 0.00001), and were significantly more resistant to type I IFNs than the corresponding donor isolates. Remarkably, transmitted viruses exhibited 7.8-fold higher IFNα2 (P < 0.00001) and 39-fold higher IFNβ (P < 0.00001) half-maximal inhibitory concentrations (IC50) than did donor isolates, and their odds of replicating in CD4+ T cells at the highest IFNα2 and IFNβ doses were 35-fold (P < 0.00001) and 250-fold (P < 0.00001) greater, respectively. Interestingly, pretreatment of CD4+ T cells with IFNβ, but not IFNα2, selected donor plasma isolates that exhibited a transmitted virus-like phenotype, and such viruses were also detected in the donor genital tract. These data indicate that transmitted viruses are phenotypically distinct, and that increased IFN resistance represents their most distinguishing property. Thus, the mucosal bottleneck selects for viruses that are able to replicate and spread efficiently in the face of a potent innate immune response.
Collapse
Affiliation(s)
- Shilpa S Iyer
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Frederic Bibollet-Ruche
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Scott Sherrill-Mix
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Gerald H Learn
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Lindsey Plenderleith
- Institute of Evolutionary Biology, and Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, United Kingdom
| | - Andrew G Smith
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Hannah J Barbian
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Ronnie M Russell
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Marcos V P Gondim
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Catherine Y Bahari
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Christiana M Shaw
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Yingying Li
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Timothy Decker
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Barton F Haynes
- Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710
- Department of Medicine, Duke University Medical Center, Durham, NC 27710
- Department of Immunology, Duke University Medical Center, Durham, NC 27710
| | - George M Shaw
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Paul M Sharp
- Institute of Evolutionary Biology, and Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, United Kingdom
| | - Persephone Borrow
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
| | - Beatrice H Hahn
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| |
Collapse
|
31
|
Barbagallo M, Musumarra A, Cosentino L, Maugeri E, Heinitz S, Mengoni A, Dressler R, Schumann D, Käppeler F, Colonna N, Finocchiaro P, Ayranov M, Damone L, Kivel N, Aberle O, Altstadt S, Andrzejewski J, Audouin L, Bacak M, Balibrea-Correa J, Barros S, Bécares V, Bečvář F, Beinrucker C, Berthoumieux E, Billowes J, Bosnar D, Brugger M, Caamaño M, Calviani M, Calviño F, Cano-Ott D, Cardella R, Casanovas A, Castelluccio DM, Cerutti F, Chen YH, Chiaveri E, Cortés G, Cortés-Giraldo MA, Cristallo S, Diakaki M, Domingo-Pardo C, Dupont E, Duran I, Fernandez-Dominguez B, Ferrari A, Ferreira P, Furman W, Ganesan S, García-Rios A, Gawlik A, Glodariu T, Göbel K, Gonçalves IF, González-Romero E, Griesmayer E, Guerrero C, Gunsing F, Harada H, Heftrich T, Heyse J, Jenkins DG, Jericha E, Katabuchi T, Kavrigin P, Kimura A, Kokkoris M, Krtička M, Leal-Cidoncha E, Lerendegui J, Lederer C, Leeb H, Lo Meo S, Lonsdale SJ, Losito R, Macina D, Marganiec J, Martínez T, Massimi C, Mastinu P, Mastromarco M, Mazzone A, Mendoza E, Milazzo PM, Mingrone F, Mirea M, Montesano S, Nolte R, Oprea A, Pappalardo A, Patronis N, Pavlik A, Perkowski J, Piscopo M, Plompen A, Porras I, Praena J, Quesada J, Rajeev K, Rauscher T, Reifarth R, Riego-Perez A, Rout P, Rubbia C, Ryan J, Sabate-Gilarte M, Saxena A, Schillebeeckx P, Schmidt S, Sedyshev P, Smith AG, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia A, Tassan-Got L, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vlachoudis V, Vlastou R, Vollaire J, Wallner A, Warren S, Weigand M, Weiß C, Wolf C, Woods PJ, Wright T, Žugec P. ^{7}Be(n,α)^{4}He Reaction and the Cosmological Lithium Problem: Measurement of the Cross Section in a Wide Energy Range at n_TOF at CERN. Phys Rev Lett 2016; 117:152701. [PMID: 27768364 DOI: 10.1103/physrevlett.117.152701] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Indexed: 06/06/2023]
Abstract
The energy-dependent cross section of the ^{7}Be(n,α)^{4}He reaction, of interest for the so-called cosmological lithium problem in big bang nucleosynthesis, has been measured for the first time from 10 meV to 10 keV neutron energy. The challenges posed by the short half-life of ^{7}Be and by the low reaction cross section have been overcome at n_TOF thanks to an unprecedented combination of the extremely high luminosity and good resolution of the neutron beam in the new experimental area (EAR2) of the n_TOF facility at CERN, the availability of a sufficient amount of chemically pure ^{7}Be, and a specifically designed experimental setup. Coincidences between the two alpha particles have been recorded in two Si-^{7}Be-Si arrays placed directly in the neutron beam. The present results are consistent, at thermal neutron energy, with the only previous measurement performed in the 1960s at a nuclear reactor. The energy dependence reported here clearly indicates the inadequacy of the cross section estimates currently used in BBN calculations. Although new measurements at higher neutron energy may still be needed, the n_TOF results hint at a minor role of this reaction in BBN, leaving the long-standing cosmological lithium problem unsolved.
Collapse
Affiliation(s)
| | - A Musumarra
- Dipartimento di Fisica e Astronomia DFA, Università di Catania, Italy
- INFN-Laboratori Nazionali del Sud, Catania, Italy
| | - L Cosentino
- INFN-Laboratori Nazionali del Sud, Catania, Italy
| | - E Maugeri
- Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - S Heinitz
- Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | | | - R Dressler
- Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - D Schumann
- Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - F Käppeler
- Karlsruhe Institute of Technology (KIT), Institut für Kernphysik, Karlsruhe, Germany
| | | | | | - M Ayranov
- European Commission, DG-Energy, Luxembourg
| | | | - N Kivel
- Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | | | - S Altstadt
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | | | - L Audouin
- Centre National de la Recherche Scientifique/IN2P3-IPN, Orsay, France
| | - M Bacak
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | - J Balibrea-Correa
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - S Barros
- C2TN-Instituto Superior Tecníco, Universidade de Lisboa, Portugal
| | - V Bécares
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - F Bečvář
- Charles University, Prague, Czech Republic
| | - C Beinrucker
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | | | - J Billowes
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Croatia
| | | | - M Caamaño
- Universidade de Santiago de Compostela, Spain
| | | | - F Calviño
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | - D Cano-Ott
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - R Cardella
- INFN-Laboratori Nazionali del Sud, Catania, Italy
- CERN, Geneva, Switzerland
| | - A Casanovas
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | | | | | - Y H Chen
- Centre National de la Recherche Scientifique/IN2P3-IPN, Orsay, France
| | | | - G Cortés
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | | | - S Cristallo
- INAF-Osservatorio Astronomico di Collurania, Teramo, Italy
| | - M Diakaki
- National Technical University of Athens (NTUA), Greece
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Spain
| | - E Dupont
- CEA/Saclay-IRFU, Gif-sur-Yvette, France
| | - I Duran
- Universidade de Santiago de Compostela, Spain
| | | | | | - P Ferreira
- C2TN-Instituto Superior Tecníco, Universidade de Lisboa, Portugal
| | - W Furman
- Joint Institute of Nuclear Research, Dubna, Russia
| | - S Ganesan
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - A García-Rios
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - A Gawlik
- Uniwersytet Łódzki, Lodz, Poland
| | - T Glodariu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest-Magurele, Romania
| | - K Göbel
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - I F Gonçalves
- C2TN-Instituto Superior Tecníco, Universidade de Lisboa, Portugal
| | - E González-Romero
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - E Griesmayer
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | | | - F Gunsing
- CEA/Saclay-IRFU, Gif-sur-Yvette, France
| | - H Harada
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - T Heftrich
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - J Heyse
- European Commission JRC, Institute for Reference Materials and Measurements, Retieseweg 111, B-2440 Geel, Belgium
| | - D G Jenkins
- University of York, Heslington, York, United Kingdom
| | - E Jericha
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | | | - P Kavrigin
- Atominstitut der Österreichischen Universitäten, Technische Universität Wien, Austria
| | - A Kimura
- Japan Atomic Energy Agency (JAEA), Tokai-mura, Japan
| | - M Kokkoris
- National Technical University of Athens (NTUA), Greece
| | - M Krtička
- Charles University, Prague, Czech Republic
| | | | | | - C Lederer
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - H Leeb
- Atominstitut der Österreichischen Universitäten, Technis che Universität Wien, Austria
| | - S Lo Meo
- ENEA, Bologna, Italy
- INFN, Sezione di Bologna, Italy
| | - S J Lonsdale
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | | | | | | | - T Martínez
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | - C Massimi
- INFN, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna
| | - P Mastinu
- INFN-Laboratori Nazionali di Legnaro, Italy
| | | | - A Mazzone
- INFN, Sezione di Bari, Italy
- CNR-IC, Bari, Italy
| | - E Mendoza
- Centro de Investigaciones Energeticas Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain
| | | | - F Mingrone
- INFN, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna
| | - M Mirea
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest-Magurele, Romania
| | | | - R Nolte
- Physikalisch Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - A Oprea
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest-Magurele, Romania
| | - A Pappalardo
- INFN-Laboratori Nazionali del Sud, Catania, Italy
| | | | - A Pavlik
- University of Vienna, Faculty of Physics, Austria
| | | | - M Piscopo
- INFN-Laboratori Nazionali del Sud, Catania, Italy
| | - A Plompen
- European Commission JRC, Institute for Reference Materials and Measurements, Retieseweg 111, B-2440 Geel, Belgium
| | | | - J Praena
- Universidad de Sevilla, Spain
- Universidad de Granada, Spain
| | | | - K Rajeev
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - T Rauscher
- Centre for Astrophysics Research, School of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, United Kingdom
- Department of Physics, University of Basel, Basel, Switzerland
| | - R Reifarth
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - A Riego-Perez
- Universitat Politecnica de Catalunya, Barcelona, Spain
| | - P Rout
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | | | - J Ryan
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | | | - A Saxena
- Bhabha Atomic Research Centre (BARC), Mumbai, India
| | - P Schillebeeckx
- European Commission JRC, Institute for Reference Materials and Measurements, Retieseweg 111, B-2440 Geel, Belgium
| | - S Schmidt
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - P Sedyshev
- Joint Institute of Nuclear Research, Dubna, Russia
| | - A G Smith
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | | | | | - J L Tain
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Spain
| | | | - L Tassan-Got
- Centre National de la Recherche Scientifique/IN2P3-IPN, Orsay, France
| | | | - S Valenta
- Charles University, Prague, Czech Republic
| | - G Vannini
- INFN, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna
| | | | - P Vaz
- C2TN-Instituto Superior Tecníco, Universidade de Lisboa, Portugal
| | | | | | - R Vlastou
- National Technical University of Athens (NTUA), Greece
| | | | - A Wallner
- University of Vienna, Faculty of Physics, Austria
- Research School of Physics and Engineering, Australian National University, ACT 0200, Australia
| | - S Warren
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - M Weigand
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - C Weiß
- CERN, Geneva, Switzerland
| | - C Wolf
- Johann-Wolfgang-Goethe Universität, Frankfurt, Germany
| | - P J Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - T Wright
- University of Manchester, Oxford Road, Manchester, United Kingdom
| | - P Žugec
- Department of Physics, Faculty of Science, University of Zagreb, Croatia
| |
Collapse
|
32
|
Kane EV, Smith AG, Howell D, Crouch S, Roman E. OP08 Emergency presentation in aggressive lymphoma and impact on survival: a report from the Haematological Malignancy Research Network. Br J Soc Med 2016. [DOI: 10.1136/jech-2016-208064.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
33
|
Howell DA, Turner AK, Smith AG, Roman E. P80 Preferred and actual place of death in patients with blood cancers: Findings from a UK population-based study. Br J Soc Med 2016. [DOI: 10.1136/jech-2016-208064.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
34
|
Howell DA, Appleton S, Smith AG, Roman E. P79 Routes to diagnosis of myeloma: findings from a UK population-based study. Br J Soc Med 2016. [DOI: 10.1136/jech-2016-208064.178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
35
|
Abstract
A new functional law of large numbers to approximate a time inhomogeneous Markov process that is only density dependent in the limit as an index parameter goes to infinity is developed. This extends previous results by other authors to a broader class of Markov processes while relaxing some of the conditions required for those results to hold. This result is applied to a stochastic metapopulation model that accounts for spatial structure as well as within patch dynamics with the novel addition of time dependent dynamics. The resulting nonautonomous differential equation is analysed to provide conditions for extinction and persistence for a number of examples. This condition shows that the migration of a species will positively impact the reproduction in less populated areas while negatively impacting densely populated areas.
Collapse
Affiliation(s)
- Andrew G Smith
- School of Mathematical Sciences, University of Adelaide, SA 5005, Australia.
| |
Collapse
|
36
|
Howell DA, Wang HI, Roman E, Smith AG, Patmore R, Johnson MJ, Garry A, Howard M. Preferred and actual place of death in haematological malignancy. BMJ Support Palliat Care 2015; 7:150-157. [PMID: 26156005 PMCID: PMC5502252 DOI: 10.1136/bmjspcare-2014-000793] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Revised: 01/19/2015] [Accepted: 06/21/2015] [Indexed: 11/11/2022]
Abstract
Objectives Home is considered the preferred place of death for many, but patients with haematological malignancies (leukaemias, lymphomas and myeloma) die in hospital more often than those with other cancers and the reasons for this are not wholly understood. We examined preferred and actual place of death among people with these diseases. Methods The study is embedded within an established population-based cohort of patients with haematological malignancies. All patients diagnosed at two of the largest hospitals in the study area between May 2005 and April 2008 with acute myeloid leukaemia, diffuse large B-cell lymphoma or myeloma, who died before May 2010 were included. Data were obtained from medical records and routine linkage to national death records. Results 323 deceased patients were included. A total of 142 (44%) had discussed their preferred place of death; 45.8% wanted to die at home, 28.2% in hospital, 16.9% in a hospice, 5.6% in a nursing home and 3.5% were undecided; 63.4% of these died in their preferred place. Compared to patients with evidence of a discussion, those without were twice as likely to have died within a month of diagnosis (14.8% vs 29.8%). Overall, 240 patients died in hospital; those without a discussion were significantly more likely to die in hospital than those who had (p≤0.0001). Of those dying in hospital, 90% and 75.8% received haematology clinical input in the 30 and 7 days before death, respectively, and 40.8% died in haematology areas. Conclusions Many patients discussed their preferred place of death, but a substantial proportion did not and hospital deaths were common in this latter group. There is scope to improve practice, particularly among those dying soon after diagnosis. We found evidence that some people opted to die in hospital; the extent to which this compares with other cancers is of interest.
Collapse
Affiliation(s)
- D A Howell
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - H I Wang
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - E Roman
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - A G Smith
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK
| | - R Patmore
- Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, UK
| | - M J Johnson
- Hull York Medical School, University of Hull, Hull, UK
| | - A Garry
- York Teaching Hospital NHS Foundation Trust, York, UK
| | - M Howard
- York Teaching Hospital NHS Foundation Trust, York, UK
| |
Collapse
|
37
|
Smith AG, Andrews S, Bratton SL, Sheetz J, Feudtner C, Zhong W, Maloney CG. Pediatric palliative care and inpatient hospital costs: a longitudinal cohort study. Pediatrics 2015; 135:694-700. [PMID: 25802343 DOI: 10.1542/peds.2014-3161] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/27/2015] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Pediatric palliative care (PPC) improves the quality of life for children with life-limiting conditions, but the cost of care associated with PPC has not been quantified. This study examined the association between inpatient cost and receipt of PPC among high-cost inpatients. METHODS The 10% most costly inpatients treated at a children's hospital in 2010 were studied, and factors associated with receipt of PPC were determined. Among patients dying during 2010, we compared 2010 inpatient costs between PPC recipients and nonrecipients. Inpatient costs during the 2-year follow up period between PPC recipients and nonrecipients were also compared. Patients were analyzed in 2 groups: those who died and those who survived the 2-year follow-up. RESULTS Of 902 patients, 86 (10%) received PPC. Technology dependence, older age, multiple chronic conditions, PICU admission, and death in 2010 were independently associated with receipt of PPC. PPC recipients had increased inpatient costs compared with nonrecipients during 2010. Among patients who died during the 2-year follow-up, PPC recipients had significantly lower inpatient costs. Among survivors, PPC recipients had greater inpatient costs. When controlling for patient complexity, differences in inpatient costs were not significant. CONCLUSIONS The relationship of PPC to inpatient costs is complex. PPC seems to lower costs among patients approaching death. Patients selectively referred to PPC who survive most often do so with chronic serious illnesses that predispose them to remain lifelong high-resource utilizers.
Collapse
Affiliation(s)
- Andrew G Smith
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah;
| | - Seth Andrews
- Primary Children's Hospital, Salt Lake City, Utah
| | - Susan L Bratton
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah
| | - Joan Sheetz
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah
| | - Chris Feudtner
- Pediatric Advanced Care Team and the Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and Department of Medical Ethics and Health Policy and the Leonard Davis Institute, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Wenjun Zhong
- Pediatric Advanced Care Team and the Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - Christopher G Maloney
- Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah
| |
Collapse
|
38
|
Abstract
Genetic variants in haem metabolism enzymes can be predisposition factors for adverse reactions in some individuals. New areas of haem biology may also be associated with idiosyncratic effects which are yet to be identified.
Collapse
Affiliation(s)
- Viktoria Vágány
- MRC Toxicology Unit
- Hodgkin Building
- University of Leicester
- Leicester LE1 9HN
- UK
| | - Andrew G. Smith
- MRC Toxicology Unit
- Hodgkin Building
- University of Leicester
- Leicester LE1 9HN
- UK
| |
Collapse
|
39
|
Hayes MD, Ovcinnikovs V, Smith AG, Kimber I, Dearman RJ. The aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell development. PLoS One 2014; 9:e106955. [PMID: 25203682 PMCID: PMC4159274 DOI: 10.1371/journal.pone.0106955] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2014] [Accepted: 08/11/2014] [Indexed: 12/30/2022] Open
Abstract
The aryl hydrocarbon receptor (AhR) has been shown to be required for optimal Thelper (Th) 17 cell activation. Th17 cells provide immunity against extracellular pathogens and are implicated in autoimmune diseases. Herein, the role of the AhR in cytokine production by Th17, and by the analogous population of T cytotoxic (Tc)17 cells, has been examined. Lymph node Tc (CD8(+)) and Th (CD4(+)) cells were isolated by negative selection from naive AhR(+/-) and AhR(-/-) mice and polarised to Tc1/Th1 or Tc17/Th17 phenotypes with appropriate cytokines. Cell differentiation was assessed as a function of mRNA and protein (ELISA and flow cytometry) expression for interferon (IFN)-γ and for key Th17 cytokines. In AhR(+/-) mice, Th17 cells displayed an exclusive IL-17 profile, which was markedly inhibited by a selective AhR antagonist to levels observed in AhR knockout mice. Addition of the natural AhR agonist 6-formylindolo[3,2-b]carbazole (FICZ) markedly enhanced Th17 cell activity in the heterozygotes. In contrast, Tc17 cells polarised into 3 distinct subsets: producing either IL-17 or IFN-γ alone, or both cytokines. Blocking AhR was also detrimental to Tc17 development, with reduced responses recorded in AhR(-/-) mice and antagonist-mediated reduction of IL-17 expression in the heterozygotes. However, Tc17 cells were largely refractory to exogenous FICZ, presumably because Tc17 cells express baseline AhR mRNA, but unlike Th17 cells, there is no marked up-regulation during polarisation. Thus, Th17 cell development is more dependent upon AhR activation than is Tc17 cell development, suggesting that endogenous AhR ligands play a much greater role in driving Th17 cell responses.
Collapse
Affiliation(s)
- Mark D. Hayes
- Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom
| | - Vitalijs Ovcinnikovs
- Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom
| | - Andrew G. Smith
- MRC Toxicology Unit, The University of Leicester, Leicester, United Kingdom
| | - Ian Kimber
- Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom
| | - Rebecca J. Dearman
- Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom
| |
Collapse
|
40
|
Robinson SW, Davies R, Vágány V, Smith AG. Complex susceptibility factors suggest new mechanisms of disruption of murine hepatic haem synthesis by chemicals in association with iron. Toxicol Lett 2014. [DOI: 10.1016/j.toxlet.2014.06.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
41
|
Abstract
The gene regulatory circuitry through which pluripotent embryonic stem (ES) cells choose between self-renewal and differentiation appears vast and has yet to be distilled into an executive molecular program. We developed a data-constrained, computational approach to reduce complexity and to derive a set of functionally validated components and interaction combinations sufficient to explain observed ES cell behavior. This minimal set, the simplest version of which comprises only 16 interactions, 12 components, and three inputs, satisfies all prior specifications for self-renewal and furthermore predicts unknown and nonintuitive responses to compound genetic perturbations with an overall accuracy of 70%. We propose that propagation of ES cell identity is not determined by a vast interactome but rather can be explained by a relatively simple process of molecular computation.
Collapse
Affiliation(s)
- S-J Dunn
- Computational Science Laboratory, Microsoft Research, Cambridge, CB1 2FB, UK
| | - G Martello
- Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 1QR, UK
| | - B Yordanov
- Computational Science Laboratory, Microsoft Research, Cambridge, CB1 2FB, UK
| | - S Emmott
- Computational Science Laboratory, Microsoft Research, Cambridge, CB1 2FB, UK
| | - AG Smith
- Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 1QR, UK
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| |
Collapse
|
42
|
Bruton MJ, McAlpine CA, Smith AG, Franklin CE. The importance of underground shelter resources for reptiles in dryland landscapes: A woma python case study. AUSTRAL ECOL 2014. [DOI: 10.1111/aec.12150] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Melissa J. Bruton
- Landscape Ecology and Conservation Group; School of Geography, Planning and Environmental Management; The University of Queensland; Brisbane Qld 4072 Australia
| | - Clive A. McAlpine
- Landscape Ecology and Conservation Group; School of Geography, Planning and Environmental Management; The University of Queensland; Brisbane Qld 4072 Australia
- National Environmental Research Program for Environmental Decisions; The University of Queensland; Brisbane Queensland Australia
| | - Andrew G. Smith
- Landscape Ecology and Conservation Group; School of Geography, Planning and Environmental Management; The University of Queensland; Brisbane Qld 4072 Australia
| | - Craig E. Franklin
- School of Biological Sciences; The University of Queensland; Brisbane Queensland Australia
| |
Collapse
|
43
|
Howell DA, Wang HI, Roman E, Smith AG, Patmore R, Johnson MJ, Garry AC, Howard MR. Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma. BMJ Support Palliat Care 2014; 5:496-502. [PMID: 24644210 PMCID: PMC4717425 DOI: 10.1136/bmjspcare-2013-000578] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2013] [Accepted: 01/19/2014] [Indexed: 11/06/2022]
Abstract
Objective To develop and implement a methodology for capturing complete haematological malignancy pathway data and use it to identify variations in specialist palliative care (SPC) referrals. Methods In our established UK population-based patient cohort, 323 patients were diagnosed with acute myeloid leukaemia, diffuse large B-cell lymphoma or myeloma between May 2005 and April 2008, and died before April 2010. A day-by-day calendar approach was devised to collect pathway data, including SPC referrals, to supplement routinely collected information on clinical presentation, diagnosis, treatment, response, and date and place of death. Results 155 (47.9%) of the 323 patients had at least one SPC referral. The likelihood of referral increased with survival (OR 6.58, 95% CIs 3.32 to 13.03 for patients surviving ≥1 year compared to ≤1 month from diagnosis), and varied with diagnosis (OR 1.96, CIs 1.15 to 3.35 for myeloma compared to acute myeloid leukaemia). Compared to patients dying in hospital, those who died at home or in a hospice were also more likely to have had an SPC referral (OR 3.07, CIs 1.59 to 5.93 and 4.74, CIs 1.51 to 14.81, respectively). No associations were found for age and sex. Conclusions Our novel approach efficiently captured pathway data and SPC referrals, revealing evidence of greater integration between haematology and SPC services than previously reported. The likelihood of referral was much higher among those dying outside hospital, and variations in practice were observed by diagnosis, emphasising the importance of examining diseases individually.
Collapse
Affiliation(s)
- D A Howell
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, North Yorkshire, UK
| | - H-I Wang
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, North Yorkshire, UK
| | - E Roman
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, North Yorkshire, UK
| | - A G Smith
- Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, North Yorkshire, UK
| | - R Patmore
- Queens Centre for Oncology, Castle Hill Hospital, Hull, East Yorkshire, UK
| | - M J Johnson
- Hull York Medical School, The University of Hull, Hull, East Yorkshire, UK
| | - A C Garry
- York Teaching Hospital NHS Foundation Trust, York, North Yorkshire, UK
| | - M R Howard
- York Teaching Hospital NHS Foundation Trust, York, North Yorkshire, UK
| |
Collapse
|
44
|
Smith AG, Painter D, Howell DA, Evans P, Smith G, Patmore R, Jack A, Roman E. Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort. BMJ Open 2014; 4:e004266. [PMID: 24435897 PMCID: PMC3902525 DOI: 10.1136/bmjopen-2013-004266] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2013] [Revised: 12/03/2013] [Accepted: 12/05/2013] [Indexed: 01/13/2023] Open
Abstract
OBJECTIVES To examine contemporary survival patterns in the general population of patients diagnosed with chronic myeloid leukaemia (CML), and to identify patient groups with less than optimal outcomes. DESIGN Prospective population-based cohort. SETTING The UK's Haematological Malignancy Research Network (catchment population 3.6 million, with >2000 new haematological malignancies diagnosed annually). PARTICIPANTS All patients newly diagnosed with CML, from September 2004 to August 2011 and followed up to 31 March 2013. MAIN OUTCOME MEASURE Incidence and survival. RESULTS With a median diagnostic age of 59 years, the CML age standardised (European) incidence was 0.9/100 000 (95% CIs 0.8 to 0.9), 5-year overall survival was 78.9% (72.3 to 84.0) and 5-year relative survival 88.6% (81.0 to 93.3). The efficacy of treatment across all ages was clearly demonstrated; the relative survival curves for those under 60 and over 60 years being closely aligned. Survival findings were similar for men and women, but varied with deprivation; the age and sex adjusted HR being 3.43 (1.89 to 6.22) for deprivation categories 4-5 (less affluent) versus 1-3 (more affluent). None of these differences were attributable to the biological features of the disease. CONCLUSIONS When therapy is freely provided, population-based survival for CML is similar to that reported in clinical trials, and age loses its prognostic significance. However, although most of the patients with CML now experience close to normal lifespans, those living in more deprived areas tend to have poorer outcomes, despite receiving the same clinical care. A significant improvement in overall population outcomes could be achieved if these socioeconomic differences, which may reflect the treatment compliance, could be eliminated.
Collapse
Affiliation(s)
- A G Smith
- Department of Health Sciences, University of York, York, UK
| | - D Painter
- Department of Health Sciences, University of York, York, UK
| | - D A Howell
- Department of Health Sciences, University of York, York, UK
| | - P Evans
- Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, UK
| | - G Smith
- St. James's Institute of Oncology, St James's University Hospital, Leeds, UK
| | - R Patmore
- Queens Centre for Oncology, Castle Hill Hospital, Hull, UK
| | - A Jack
- Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, UK
| | - E Roman
- Department of Health Sciences, University of York, York, UK
| |
Collapse
|
45
|
Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME, Pereira SE, Kempenich JH, Reed EF, Setterholm M, Smith AG, Tilanus MG, Torres M, Varney MD, Voorter CEM, Fischer GF, Fleischhauer K, Goodridge D, Klitz W, Little AM, Maiers M, Marsh SGE, Müller CR, Noreen H, Rozemuller EH, Sanchez-Mazas A, Senitzer D, Trachtenberg E, Fernandez-Vina M. Common and well-documented HLA alleles: 2012 update to the CWD catalogue. ACTA ACUST UNITED AC 2013; 81:194-203. [PMID: 23510415 DOI: 10.1111/tan.12093] [Citation(s) in RCA: 173] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2013] [Revised: 02/14/2013] [Accepted: 02/15/2013] [Indexed: 11/26/2022]
Abstract
We have updated the catalogue of common and well-documented (CWD) human leukocyte antigen (HLA) alleles to reflect current understanding of the prevalence of specific allele sequences. The original CWD catalogue designated 721 alleles at the HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, and -DPB1 loci in IMGT (IMmunoGeneTics)/HLA Database release 2.15.0 as being CWD. The updated CWD catalogue designates 1122 alleles at the HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1 and -DPB1 loci as being CWD, and represents 14.3% of the HLA alleles in IMGT/HLA Database release 3.9.0. In particular, we identified 415 of these alleles as being 'common' (having known frequencies) and 707 as being 'well-documented' on the basis of ~140,000 sequence-based typing observations and available HLA haplotype data. Using these allele prevalence data, we have also assigned CWD status to specific G and P designations. We identified 147/151 G groups and 290/415 P groups as being CWD. The CWD catalogue will be updated on a regular basis moving forward, and will incorporate changes to the IMGT/HLA Database as well as empirical data from the histocompatibility and immunogenetics community. This version 2.0.0 of the CWD catalogue is available online at cwd.immunogenomics.org, and will be integrated into the Allele Frequencies Net Database, the IMGT/HLA Database and National Marrow Donor Program's bioinformatics web pages.
Collapse
Affiliation(s)
- S J Mack
- Center for Genetics, Children's Hospital Oakland Research Institute, Oakland, CA, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Smith AG, McAlpine C, Rhodes J, Seabrook L, Lunney D, Baxter G. Are there habitat thresholds in koala occupancy in the semiarid landscapes of the Mulgalands Bioregion? Wildl Res 2013. [DOI: 10.1071/wr13010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Context
Habitat thresholds are the critical point(s), below which the probability of occurrence of a species declines. Identifying thresholds assists land managers to decide how much habitat is needed to conserve a species. However, for any given species, a threshold may not exist, or might occur at one scale but not at others, and it may differ across regions. The use of critical habitat thresholds can negatively affect populations if simplified conservation targets for habitat retention are prescribed. This problem is relevant to the koalas where there is evidence of habitat thresholds in mesic regions, but no studies of thresholds in semiarid regions.
Aims
The aim of the present study was to investigate whether a threshold exists between the occupancy of a site by koalas and habitat variables at both the site and at four landscape scales in the semiarid Mulgalands Bioregion of Queensland, Australia.
Methods
We modelled habitat relationships using standard and piece-wise logistic regression, and an information-theoretic approach, to determine whether the best model that explained the occupancy–habitat relationships was linear or had a distinct threshold. The site-scale variable was the percentage of primary eucalypt species. The landscape-scale variables included the amount of primary and secondary habitat, and an interaction between them.
Key findings
There was a threshold relationship between the occurrence of koalas and the percentage of primary trees at the site scale. At the landscape scale, most threshold models failed to converge, and evidence pointed to a linear relationship between habitat amount and koala occupancy.
Conclusions
Conservation actions for koalas in the Mulgalands Bioregion should concentrate on protecting the primary tree resource for koalas, namely, river red gums (E. camaldulensis). However, the maintenance or restoration of primary and secondary habitat to distances of 1000 m from the creek is important because of the linear relationship between koala presence and habitat amount.
Implications
As habitat is lost in the semiarid Mulgalands Bioregion, koala occupancy declines. If known thresholds from mesic regions are used to define a minimum amount of habitat to be retained for koalas, conservation of local koala populations may well fail.
Collapse
|
47
|
Boger MS, Hulgan T, Haas DW, Mitchell V, Smith AG, Singleton JR, Peltier AC. Measures of small-fiber neuropathy in HIV infection. Auton Neurosci 2012; 169:56-61. [PMID: 22542355 DOI: 10.1016/j.autneu.2012.04.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2011] [Revised: 03/28/2012] [Accepted: 04/03/2012] [Indexed: 11/25/2022]
Abstract
INTRODUCTION Noninvasive methods are needed to detect distal sensory polyneuropathy in HIV-infected persons on antiretroviral therapy (ART). METHODS Quantitative sudomotor axon reflex test (QSART) and Utah Early Neuropathy Scale (UENS), small-fiber sensitive measures, were assessed in subjects with and without clinical neuropathy. Pain was assessed by visual analog scale (VAS). RESULTS Twenty-two subjects had symptoms and signs of neuropathy, 19 had neither, and all were receiving ART. Median sweat volume (μL) was lower at all testing sites in those with neuropathy compared to those without (p<0.01 for all). UENS and VAS (mm) were higher in neuropathy subjects (p<0.05 for each). Lower sweat volume at all sites correlated with higher pin UENS subscore, total UENS, and VAS (p<0.05 for all). In multivariable analyses adjusting for age, CD4⁺ T cells, sex, and use of "d-drug" ART, QSART and UENS remained associated (p=0.003). CONCLUSION QSART and UENS have not been previously studied in this patient population and may identify small-fiber neuropathy in HIV-infected, ART-treated persons.
Collapse
Affiliation(s)
- M S Boger
- Department of Medicine, Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC 29412, United States.
| | | | | | | | | | | | | |
Collapse
|
48
|
Smith AG, Fan W, Regen L, Warnock S, Sprague M, Williams R, Nisperos B, Zhao LP, Loken MR, Hansen JA, Pereira S. Somatic mutations in the HLA genes of patients with hematological malignancy. ACTA ACUST UNITED AC 2012; 79:359-66. [PMID: 22489945 DOI: 10.1111/j.1399-0039.2012.01868.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- A G Smith
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
The use of organochlorine insecticides such as DDT, lindane and cyclodieneshas declined markedly worldwide over the last decades. Most are now banned or not used. At an acute toxicity level they have been relatively safe in use for humans. However, the greatest concerns are their persistence in people, wildlife and the environment due to their slow metabolism. Although their carcinogenicity for humans has not been supported by strong epidemiological evidence, their potential to be modulators of endocrine and immune function at levels remaining in the environment or associated with residual spraying of DDT continue to be of concern. At present, DDT is still allowed by the United Nations for combating malaria, with continual monitoring and assessment where possible. The toxicological consequences of exposure of animals and people to DDT is discussed as well as some analogues and other insecticides such as lindane, dieldrin and chlordecone that, although little used, continue to persist in surroundings and people. Because of circumstances of world health brought about by climate change or human activities that have yet to develop, there may come a time when the importance of some may re-emerge.
Collapse
Affiliation(s)
- Andrew G Smith
- MRC Toxicology Unit, University of Leicester Lancaster Road, Leicester UK.
| |
Collapse
|
50
|
Chernova T, Steinert JR, Richards P, Mistry R, Challiss RJ, Smith AG, Forsythe ID. Deficiency of regulatory heme causes an early synaptic failure in cultured neurons. Toxicology 2011. [DOI: 10.1016/j.tox.2011.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|